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Sänkyn kans
Tätä mää epäli. Mun sänk o masentunu.
Hän makka kaikep päivä pujamas ja huaaakaile vaan kova ääne.
Mää oti Mee naiste testi ja kyseli:
1.   Onk paha miäl?          O.
2.   Eik mikkä huvit?        Ei.
3.   Väsyttäk?               Nimpaljessuksest.
4.   Tulek uni?              Ei millä.
5.   Paruttak?               Valla.
6.   Nauruttak?              Mikkä.
7.   Ark kaattu pääl?        Ko sein.
8.   Onk vaikkia?            Voi voi senttä.
9.   Misä unelma ova?        Hevom persses.
10.  Es sunkka sää ittiäs    Onk sänkyjaloil kiivet
     tappa meina?            parvekken kaitte yli?
An mää auta.
(Heli Laaksonen, Pulu uis 2000)
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TIIVISTELMÄ
Vantaan terveyskeskuksen masennustutkimus (PC-VDS) on perusterveydenhuollon (PTH)
masennuspotilaiden etenevä seurantatutkimus ja osa Kansanterveyslaitoksen mielenterveys- ja
alkoholitutkimusyksikön ja Vantaan sosiaali- ja terveystoimen yhteistyöhanketta. PC-VDS:n
tarkoituksena on luoda aiempaa kattavampi käsitys PTH:n potilaiden depressiosta sekä
verrata vakavaan masennustilaan liittyviä eroja ja yhteneväisyyksiä PTH:n ja psykiatrisen
erikoissairaanhoidon potilaiden välillä.
Kolmen vantaalaisen terveysaseman 1111 satunnaista potilasta täyttivät Prime-MD − kyselyn.
Heistä niitä, jotka kyselyssä ilmaisivat masennusoireita, haastateltiin vielä puhelimitse.
Diagnostiseen haastatteluun (DSM-Axis I Disorders, SCID-I/P) kutsuttiin ne, joilla oli
vähintään kaksi viikkoa jatkunut masentunut mieliala tai kiinnostuksen tai mielihyvän
menetys. Lopullisen tutkimuskohortin muodostivat ne 137 potilasta, joilla oli
masennustilan diagnostisista oireista vähintään kaksi sekä niiden aiheuttamaa kärsimystä
tai toimintakyvyn heikkenemistä.
Tutkimuspotilailta kerättiin sekä poikkileikkauksellisia että takautuvia tietoja
henkilökohtaisella haastattelulla ja kyselykaavakkeilla, lisäksi käytössä oli kaikki
mahdolliset sairauskertomustiedot. Samanaikaisia muita psykiatrisia häiriöitä selvitettiin
puolistrukturoiduilla diagnostisilla haastattelumenetelmillä (DSM-Axis I Disorders,
SCID-I/P; DSM-IV Axis II Disorders, SCID-II). Itsetuhokäyttäytymistä selvitettiin
sairauskertomustiedoista, haastattelemalla ja Scale for Suicidal Ideation − kysely-
lomakkeella.
Koska PCV-DS:n tutkimusmenetelmät olivat vertailukelpoisia Vantaan depressiotutkimuksen
(VDS) kanssa, PC-VDS:n vakavasta masennustilasta (MDD) kärsivien, 20-59-vuotiaiden
potilaiden (N=79) kliinisiä ominaisuuksia voitiin verrata VDS:n psykiatristen
avohoitopotilaiden (N=223) ja sairaalapotilaiden (N=46) ominaisuuksiin.
Seurannassa PC-VDS:n potilaita tutkittiin 3, 6 ja 18 kuukauden kuluttua. Koko seurantaan
osallistui 123 potilasta (90%). Indeksimasennusjakson kestoa ja masennustilan
uusiutumisten tai uudelleenpuhkeamisten ajoittumista tutkittiin yksityiskohtaisen
graafisen elämänkaarikäyrän (life-chart) avulla.
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Alkututkimuksessa osoittautui, että useimmilla potilailla (66%) oli ajankohtainen MDD ja
lähes kaikilla (90%) oli ollut MDD jossain elämänsä vaiheessa. Alkututkimuksessa 34%
potilaista poti "lieviä masennusoireita", jotka eivät täyttäneet ajankohtaisen MDD:n
kriteereitä. Heistä kahdella kolmasosalla oli ollut vakava masennusjakso, mutta
tutkimushetkellä he olivat joko jo osittain toipuneet siitä tai mahdollisesti heille oli
puhkeamassa uusi MDD:n jakso. Tutkimuksessa MDD:t olivat yleensä toistuvia ja kroonisuus
oli tavallista. Depressioon liittyi oheissairautena psykiatrinen akseli I:n häiriö 59 %
potilaista, 52 % oli persoonallisuushäiriö ja 47 % krooninen fyysinen sairaus; vain 12 %
ei ollut mitään oheissairauksia.
Tutkimuspotilaista kuudesosa (17%) oli yrittänyt itsemurhaa, lisäksi kolmannes (37 %) oli
vakavasti harkinnut sitä. Itsetuhoista käyttäytymistä ilmeni lähinnä niillä, joilla oli
keskivaikea tai vaikea MDD, persoonallisuushäiriö sekä aiempi erikoissairaanhoitotasoinen
psykiatrinen hoito. Suurin osa oli saanut nykyiseenkin masennusjaksoon terveyskeskuksessa
hoitoa, mutta itsemurha-ajatukset olivat jääneet pääosin tunnistamatta siellä.
PTH:n potilaiden ja psykiatrisen erikoissairaanhoitoon otettujen potilaiden vertailu
paljasti, että suurin osa itsetuhoisista tai psykoottisista MDD-potilaista oli
erikoissairaanhoidon piirissä ja että kaikkein vakavimmin oireilevat ja toimintakykynsä
menettäneet potilaat olivat sairaalahoidossa.
Muiden kliinisten ominaisuuksien suhteen PTH:n ja psykiatrisen avohoidon MDD-potilaat
olivat yllättävän samankaltaisia. Monella nyt PTH:n hoidossa olevalla MDD-potilaalla
osoittautui olleen nykyisen masennustilajakson aikana erikoissairaanhoitotason
psykiatrinen hoitokontakti.
Seurantatutkimuksessa korostui PTH:n depression kroonisuus ja toistuvuus. Puolentoista
vuoden aikana vain neljännes MDD-potilaista pysyi toipumisen jälkeen oireettomana, kun
taas toisella neljänneksellä toipuminen ei käynnistynyt lainkaan. Muut potilaat joko
kärsivät depression jäännösoireista tai he sairastuivat uudestaan. Alkututkimuksessa
kartoitetuista ilmiöistä parhaiten toipumista ennusti masennusoireiden vaikeusaste; myös
päihdeongelmat, krooniset fyysiset sairaudet ja C-ryhmän persoonallisuushäiriöt ennustivat
huonoa toipumista.
Tämän tutkimuksen perusteella PTH:n potilaiden lievätkin masennusoireet saattavat usein
ilmentää sairastetun MDD:n jäännösoireita ja edellyttää hoidon arviointia. Itsemurhien
ehkäisyn kannalta korkean riskin potilaiden itsetuhoiset ajatukset pitäisi depression
hoidon yhteydessä tunnistaa paremmin. Depression hoitomalleja suunniteltaessa tulee
huomioida PTH:n depression runsas toistuvuus ja kroonistuminen, jolloin kirjallisuuden
mukaan tarvitaan mm. hoidon seurantaan erikoistunutta henkilökuntaa ja PTH:n ja
erikoissairaanhoidon saumatonta yhteistyötä. Sen lisäksi myös mielekkääseen työnjakoon
tulee panostaa, jotta depressiopotilaat saavat mahdollisimman tehokasta apua.
Avansanat: depressio, masennusoireet, perusterveydenhuolto, terveyskeskus
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1  ABSTRACT
The Vantaa Primary Care Depression Study (PC-VDS) is a naturalistic and prospective cohort
study concerning primary care patients with depressive disorders. It forms a collaborative
depression research project between the Department of Mental Health and Alcohol Research
of the National Public Health Institute, and the Primary Health Care Organization of the City
of Vantaa. The aim is to obtain a comprehensive view on clinically significant depression
in primary care, and to compare depressive patients in primary care and in secondary
level psychiatric care in terms of clinical characteristics relating to treatment needs.
Consecutive patients (N=1111) in three primary care health centres were screened for
depression with the PRIME-MD, and positive cases interviewed by telephone. Cases with
current depressive symptoms were diagnosed face-to-face with the Structured Clinical
Interview for DSM-IV Axis I Disorders (SCID-I/P). A cohort of 137 patients with unipolar
depressive disorders, comprising all patients with at least two depressive symptoms and
clinically significant distress or disability, was recruited. The Structured Clinical
Interview for DSM-IV Axis II Disorders (SCID-II), medical records, rating scales,
interview and a retrospective life-chart were used to obtain comprehensive cross-sectional
and retrospective longitudinal information. For investigation of suicidal behaviour the
Scale for Suicidal Ideation (SSI), patient records and the interview were used.
The methodology was designed to be comparable to The Vantaa Depression Study (VDS)
conducted in secondary level psychiatric care. Comparison of major depressive disorder
(MDD) patients aged 20-59 from primary care in PC-VDS (N=79) was conducted with new
psychiatric outpatients (N=223) and inpatients (N=46) in VDS.
The PC-VDS cohort was prospectively followed up at 3, 6 and 18 months. Altogether 123
patients (90%) completed the follow-up, including 79 with baseline MDD and 44 with
baseline subsyndromal disorders. Duration of the index episode and the timing of relapses
or recurrences were examined using a life-chart.
The retrospective investigation revealed current MDD in most (66%), and lifetime MDD in
nearly all (90%) cases of clinically significant depressive syndromes. Two thirds of the
"subsyndromal" cases had a history of major depressive episode (MDE), although they were
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currently either in partial remission or a potential prodromal phase. Recurrences and
chronicity were common. The picture of depression was complicated by Axis I co-morbidity
in 59%, Axis II in 52% and chronic Axis III disorders in 47%; only 12% had no
co-morbidity.
Within their lifetimes, one third (37%) had seriously considered suicide, and one sixth
(17%) had attempted it. Suicidal behaviour clustered almost exclusively in patients with
moderate to severe MDD, co-morbidity with personality disorders, and a history of
treatment in psychiatric care. The majority had received treatment for depression, but
suicidal ideation had mostly remained unrecognised.
The comparison of patients with MDD in primary care to those in psychiatric care revealed
that the majority of suicidal or psychotic patients were receiving psychiatric treatment,
and the patients with the most severe symptoms and functional limitations were
hospitalized. In other clinical aspects, patients with MDD in primary care were
surprisingly similar to psychiatric outpatients. Mental health contacts earlier in the
current MDE were common among primary care patients.
The 18-month prospective investigation with a life-chart methodology verified the chronic
and recurrent nature of depression in primary care. Only one-quarter of patients with MDD
achieved and maintained full remission during the follow-up period, while another quarter
failed to remit at all. The remaining patients suffered either from residual symptoms or
recurrences. While severity of depression was the strongest predictor of recovery,
presence of co-morbid substance use disorders, chronic medical illness and cluster C
personality disorders all contributed to an adverse outcome.
In clinical decision making, beside severity of depression and co-morbidity, history of
previous MDD should not be ignored by primary care doctors while depression there is
usually severe enough to indicate at least follow-up, and concerning those with residual
symptoms, evaluation of their current treatment. Moreover, recognition of suicidal
behaviour among depressed patients should also be improved. In order to improve outcome of
depression in primary care, the often chronic and recurrent nature of depression should be
taken into account in organizing the care. According to literature management programs of
a chronic disease, with enhancement of the role of case managers and greater integration
of primary and specialist care, have been successful. Optimum ways of allocating resources
between treatment providers as well as within health centres should be found.
Keywords: depression, primary care, subsyndromal depression
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2  LIST OF ORIGINAL PUBLICATIONS
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II  Vuorilehto MS, Melartin TK, Isometsä ET:
      Suicidal behaviour among primary-care patients with depressive disorders.
      Psychol Med. 2006 Feb;36(2):203-10.
III Vuorilehto MS, Melartin TK, Rytsälä HJ, Isometsä ET:
      Do characteristics of patients with major depressive disorder differ between
      primary and psychiatric care?
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These articles are reproduced with the kind permission of their copyright holders.
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3  INTRODUCTION
The word depression refers to a sense of lowering, the feeling of being pressed down, and
the experience of loss (the de-prefix implying deletion of something − of interest, of hope,
of energy) (Oxford English Dictionary). These meanings suggest a lack of interest in
habitual activities, an inability to experience pleasure and feeling of personal
worthlessness. Disappointment, loss or other painful events in life commonly cause
self-limited depressive affects or feelings which mostly do not interfere with a person’s
functional capacity, unless becoming longer lasting.
The concept of depression as a medical condition appeared in medical literature in Robert
Burton’s Anatomy of Melancholy in 1621. He described in detail the psychological and
social causes, such as poverty, fear and solitude, that were associated with melancholia.
Now for a few decades, especially within those branches of medicine connected with mental
health − mainly psychiatry and general practice − depression as a medical condition has
been in the focus in the development of practice guidelines and treatment programs. This
has been promoted by governments in public campaigns such as The Ostrobothnia Project in
Finland and the European Alliance against Depression.
Compared with other medical diagnoses, depressive disorders are common; every sixth person
will suffer from major depressive disorder during their lifetime, women twice as often as
men. It is especially common in many non-psychiatric medical settings, such as inpatients
wards and in chronically ill patients. Although depressive symptoms in many people recover
rapidly, the likelihood of a new episode of depression is high and increases after every
new episode. A significant minority of patients will suffer from persistent depression.
Considering this, managing depression as a chronic disease should be considered an option
in health care systems.
Depression has a considerable impact on the lives of those who experience it and their
families, and also has a substantial economic effect on society. Even milder depressive
disorders impair the functional capacity, leading to difficulties in social and marital
relations, or in work. Another crucial aspect is the increased mortality associated with
depression. This is usually a result of suicide, though the risk of premature death in
cardiovascular diseases is also elevated. The total number of suicides in many countries
exceeds the traffic mortality and amounts to near one million every year in the world. By
the year 2020, depression is assumed to have an effect on disability and mortality second
only to cardiovascular disease.
Treating depression effectively is therefore essential. Even in Europe, however, only a
minority of those with major depression seeks or receives treatment. Although the severity
of depression correlates with the probability of treatment, only about half of persons
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with serious depression in developed countries and a quarter in less-developed countries
receive treatment. Furthermore, the quality of offered treatment is suboptimal especially
in primary care. Any discussion of the epidemic rise in prescriptions of antidepressants
together with popular scepticism towards antidepressant treatments has to be considered
against this background.
In the aspect of public health, primary health care clearly acts as the basis for the care
of depression. Primary health care provides keys for promoting health and preventing
disease among regularly seen patients and serves as the basis for early detection,
intervention and long-term disease management. Most national suicide prevention strategies
challenge primary care to improve detection and management of depression. Referral to
psychiatric care is commonly recommended only for a minority of patient groups in need of
ambulatory services or with characteristics related to poor prognosis. Therefore,
depression in primary health care should form a priority area of depression research.
The Vantaa Primary Care Depression Study (PC-VDS) is a prospective, naturalistic cohort
study of 137 primary care patients with depressive disorder. In the PC-VDS the clinical
characteristics of patients with depression are investigated and predictors of chronicity,
recurrences and suicidal behaviour are assessed. The present thesis focuses on current
co-morbidity and suicidal behaviour in depressive primary care patients and compares them
with secondary care psychiatric patients. It also investigates the outcome among
depressive patients followed up for 18 months.
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4  REVIEW OF THE LITERATURE
4.1 Depression as an affect
The term depression in everyday language covers a wide range of meanings from the
temporary decrease of mood to deeply impaired, even life-threatening disorders.
Disappointment, loss or other painful events in life may all serve as trigger for
depressive affects or feelings which are self-limited and do not usually significantly
interfere with a person’s functional capacity, unless becoming longer lasting. It has been
postulated that in some situations depressive affect might even be an evolutionary useful
reaction in redefinition of goals and reallocation of efforts (Nesse et al., 2006). As
used in this thesis, depression refers to a constellation including not only mood, but
also physical, mental and behavioural experiences that define more prolonged, impairing
and severe conditions that may be clinically diagnosable as a syndrome of depression.
Depressed people may differ from one another by the number, unique patterns and severity
of symptoms, but in all depressive disorders some features are present from the domains of
affect, cognition, behaviour and physical functioning.
4.2 Psychiatric diagnoses and their validity
Classification and subtyping of diseases, that is, diagnoses, serve the purposes of
etiologic research, prognosis and prediction of treatment response. Explicit psychiatric
diagnostic criteria, since the Diagnostic and Statistical Manual of Mental Disorders, 3rd
edition (DSM-III) (APA, 1980) became a norm in research, provided a universal language in
teaching, and improved communication between the users of psychiatric services, caregivers
and society at large. The reliability of diagnoses in clinical practice improved hugely
with the introduction of explicit definitions (Kendell et al., 2003).
Although reliability is a necessity, it is not a sufficient precondition to validity
(Kendell et al., 2003). While it may be appropriate to base epidemiological research and
treatment trials on syndromes in clinical use with no proofs of validity, etiologic
research needs valid criteria (Kendell et al., 2003). In psychiatry, criteria of validity
of a diagnosis can be described as follows: 1) antecedent validators (familiar
aggregation, premorbid personality, demographic factors, precipitating factors),
2) concurrent validators  (symptom  profiles, psychological  tests, biological  markers),
3) predictive validators (diagnostic stability over time, outcome, response to treatment) and
4) delimitation from other disorders (Kendell et al., 2003).
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Most of the specifically delineated disorders captured in current diagnostic
classifications, however, are not completely discrete entities with absolute boundaries
that separate them from other disorders (Kendell et al., 2003). The categorical diagnoses
are likely to represent a heterogeneous set of disorders that are derived from a wide
range of etiological and genetic factors (Charney et al., 2004). In attempting to solve
this problem, some researchers suggest new, narrower or broader borders for mood
disorders. Others suggest dimensional measuring of narrow symptoms instead of syndromes
(Angst et al., 1997).
4.3 Diagnosis of depressive disorders
Research programmes, such as this thesis, usually apply the DSM classification rather than
the International Classificaton of Disease (ICD) (WHO) as it provides more detailed
guidelines for case definition. According to DSM-IV (APA, 1994) depressive disorders take
one of three forms: major depressive episode (MDE), dysthymic disorder or "depression not
otherwise specified", which includes several forms of briefer or milder periods of
depression. Major depressive disorder (MDD) consists of one or more MDE (Figure 1.).
MDE may be classified as mild, moderate or severe (with or without psychotic features),
based on the number and severity of symptoms, and the degree of functional disability and
distress (APA, 1994, 2000). DSM-IV and ICD-10 diagnoses of MDD differ slightly: in ICD-10
the core symptoms are added with loss of energy and two of the three core symptoms have to
be present. Also worthlessness and inappropriate guilt are defined as separate symptoms.
Dysthymic disorder in DSM-IV consists of chronic but milder symptoms than MDE (Figure 2.).
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Figure 1. The diagnostic criteria for Major Depressive Episode in DSM-IV (APA, 1994).
     A. Five of the following symptoms have been present during
        the same 2-week period and represent a change from previous
        functioning: at least one of the symptoms is either 1) or 2)
           1) Depressed mood most of the day, nearly every day,
              as indicated by either subjective report or
              observation made by others
           2) Markedly diminished interest or pleasure in all,
              or almost all activities most of the day,
              nearly every day
           3) Significant weight loss when not dieting or weight
              gain, or decrease or increase in appetite
              nearly every day
           4) Insomnia or hypersomnia nearly every day
           5) Psychomotor agitation or retardation nearly every day
           6) Fatigue or loss of energy nearly every day
           7) Feelings of worthlessness or excessive or inappropriate
              guilt nearly every day
           8) Diminished ability to think or concentrate or
              indecisiveness nearly every day
           9) Recurrent thoughts of death, recurrent suicidal ideation
              without a specific plan, or a suicide attempt or
              a specific plan for committing suicide
     B. The symptoms do not meet criteria for a Mixed episode
     C. The symptoms cause clinically significant distress or
        impairment in social, occupational or other important
        areas of functioning
     D. The symptoms are not due to the direct physiological
        effects of a substance or a general medical condition
     E. The symptoms are not better accounted for by bereavement,
        i.e., after the loss of a loved one, the symptoms persist for
        longer than 2 months or are characterized by marked functional
        impairment, morbid preoccupation with worthlessness, suicidal
        ideation, psychotic symptoms or psychomotor retardation.
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Figure 2. The diagnostic criteria for Dysthymic Disorder in DSM-IV (APA, 1994).     
     A. Depressed mood for most of the day, for more days than not,
        as indicated either by subjective account or observation by
        others, for at least 2 years
     B. Presence, while depressed, of two of the following:
           1) Poor appetite or overeating
           2) Insomnia or hypersomnia
           3) Low energy or fatigue
           4) Low self-esteem
           5) Poor concentration or difficulty making decision
           6) Feelings of hopelessness
     C. During the 2-year period of the disturbance, the person has
        never been without the symptoms of Criteria A and B for more
        than 2 months at a time
     D. No Major Depressive Episode has been present during the first
        2 years of the disturbance; i.e., the disturbance is not better
        accounted for by chronic Major Depressive Disorder, or Major
        Depressive Disorder, in partial remission
     E. There has never been a Manic Episode, a Mixed Episode or
        a Hypomanic Episode, and criteria have never been met for
        Cyclothymic Disorder
     F. The disturbance does not occur exclusively during the course of
        a chronic Psychotic Disorder, such as Schizophrenia or
        Delusional Disorder
     G. The symptoms are not due to the direct physiological effects of
        a substance or a general medical condition
     H. The symptoms cause clinically significant distress or impairment
        in social, occupational or other important areas of functioning
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Moreover, a substantial proportion of subjects with disabling depressive symptoms fail to
meet the diagnostic criteria for MDD or dysthymia, as demonstrated in many studies on
primary care patients, such as the World Health Organization (WHO) study on Psychological
Problems in General Health Care (PPGHC) (Sartorius et al., 1996). Some of these
subsyndromal conditions are included in the category Depressive disorder not otherwise
specified (APA, 1994). In literature the use of the terms describing subsyndromal
depressions is unfortunately diverse, including syndromes with varying numbers of
symptoms, with varying duration and causing varying degrees of impairment (Pincus et al.,
1999).
Subsyndromal depressive symptoms, although not a diagnostic entity, is a clinical
condition proposed by Judd in order to further analyse the pleomorphism of the depressive
spectrum in the National Institute of Mental Health (NIMH) Epidemiological Catchment Area
(ECA) Program (Judd et al., 1997). It was there defined as "at least two current
depressive symptoms, present every day for most of the time, at least two weeks, in
persons not meeting criteria for MDD, minor depression or dysthymic disorder". Thus it
could refer to residual symptoms of a past MDE or a prodromal of a future MDE (Judd et
al., 1997). In this thesis the definition suggested by Judd (1997) is used for
subsyndromal depressive disorder with one exception of demanding one of the current
symptoms to be a core symptom of MDE.
For minor depression (MinD), although not considered an official clinical diagnosis, the
American Psychiatric Association defined research diagnostic criteria in Appendix B of the
DSM-IV (APA, 1994). The essential features are identical to MDE in duration, but involve
fewer symptoms and less impairment. An episode involves either sad or depressed mood or
loss of interest or pleasure in nearly all activities. In total, at least two but less
than five additional symptoms must be present.
The Appendix B in DSM-IV (APA, 1994) also defines diagnostic criteria for recurrent brief
depressive disorder, where the episodes are identical to MDE in the number and severity of
symptoms but do not meet the 2-week duration requirement. The episodes last at least 2
days but less than two weeks. Episodes must recur minimum once a month for a period of 12
consecutive months (APA, 1994).
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4.3.1 Subgroups of depressive disorders
Diagnostic specifiers in DSM-IV define descriptively important distinctive features of
depressive episode for the purposes of research or treatment choice (APA, 1994). Psychotic
features may be present in a severe MDE, and includes presence of either hallucinations or
delusions. Psychotic depression, even more than melancholic depression, appears to be
relatively stable over repeated episodes (Coryell et al., 1994). Melancholic features of
DSM-IV MDE include lack of reactivity to pleasurable stimuli, diurnal variation of
symptoms, inappropriate guilt, early morning awakening, marked psychomotor change, either
retardation or agitation, and significant loss of appetite or weight loss. According to
Parker (Parker et al., 2005) melancholic features and psychotic features may represent a
distinctive form of severe depression arising from different pathophysiology than other
forms of depression. Depression with atypical features was first recognized in a subset of
patients with depression who preferentially responded to the monoamine oxidase inhibitors
in contrast to patients with melancholic depression (Stewart et al., 2007). Atypical
features include mood reactivity and two or more of the following: increased appetite or
weight gain, hypersomnia, leaden paralysis and long-standing interpersonal rejection
sensitivity in non-psychotic, non-melancholic MDE or dysthymic disorder (APA, 1994). The
current definition of atypical features appears problematic as interpersonal rejection
sensitivity and leaden paralysis may have their phenomenological base in anxiety rather
than depression (Parker et al., 2002). Seasonal pattern depressions have an apparent
regular onset and disappearance during certain times of the year. In the Northern
hemisphere the most common pattern is autumn or winter depressions (APA, 1994).
Postpartum onset specifier can be applied to a MDE if the onset is within 4 weeks after
the delivery of a child (APA, 1994).
4.3.2 Multiaxial assessment
Multiaxial system of DSM-IV (APA, 1994) involves an assessment on several axes, each of
which refers to a different domain of information that may help the clinician plan
treatment and predict outcome. In this thesis Axis I (clinical disorder), Axis II
(personality disorder) and Axis III (general medical condition) are used.
26
4.4 Epidemiology of depressive disorders
4.4.1 Prevalence of depressive disorders in population samples
4.4.1.1 Prevalence of MDD and dysthymia
Depressive disorders are common and distributed widely around the world (Ayuso-Mateos et
al., 2001, Alonso et al., 2004a, Demyttenaere et al., 2004). International prevalence
comparisons should, however, be made with caution, as methodological differences, among
others, render incompatibilities across available epidemiological studies (Patten, 2003).
Even the portability of MDD diagnostic criteria across countries has been questioned
(Patten, 2003).
The lifetime risk for MDD appears to be about 15% in the majority of large population
surveys such as The National Comorbidity Survey (NCS) (Kessler, 1994), the Netherlands
Mental Health Survey and Incidence Study (NEMESIS) (Bijl et al., 1998), the National
Comorbidity Survey Replication (NCS-R) (Kessler et al., 2003), the National Epidemiologic
Survey on Alcohol and Related Conditions (NESARC) (Hasin et al., 2005) and the European
Study of the Epidemiology of Mental Disorders (ESEMeD) (Alonso et al., 2004a).
Exceptionally low prevalence of MDD has been reported from Taiwan (1.5%) due at least
partly to stigma and high prevalence in Lebanon (19%) during war (Weissman et al., 1996).
The prevalence for females is about twice as high as for males (Paykel et al., 2005); it
is fairly low until early teens, when it begins to rise in roughly linear fashion
(Kessler, 1994), the median age of onset being around 30 years (Kessler et al., 2003).
Table 1. Demonstrates the large variation of one-year prevalence of MDD across studies and
sites. In 27 European studies Wittchen (2005) found variation from 3.1% to 10.1% (median
6.9%) (Wittchen et al., 2005). Even minor modifications in the diagnostic procedure, such
as CIDI vs. UM-CIDI, can lead to large changes in the results (Patten, 2003) as seen when
comparing the Ontario Health Survey in Canada (Parikh et al., 1999) and the NCS in U.S.
(Kessler, 1994) (Table 1.).
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Table 1. One year prevalences of Major Depressive Disorder in representative
national or multinational population surveys.
  Study               Country          Sample    Diagnostic     Taxonomy         Age        Prevalence
  (source)              year             size      instrument                      group      %
  ECA                   U.S.             175 211   DIS            DSM-III          18+        2.8
  (Eaton et al.,        1981
  2007)
  NCS                   U.S.               9 282   CIDI           DSM-IIIR         15-54      8.6
  (Kessler et al.,      1990-1992
  1994)
  Ontario               Canada            13 002   UM-CIDI        DSM-IIIR         15-64      4.1
  Health                1991
  Survey
  (Parikh et al.,
  1999)
  NEMESIS               Netherlands        7 076   CIDI           DSM-IIIR         18-64      5.8
  (Bijl et al.,         1996
  1998)
  NSMHWB                Australia          1 061   CIDI           DSM-IV           18+        6.3
  (Andrews et al.,      1997
  2001)
  GHS-MHS               Germany            4 181   M-CIDI         DSM-IV           18-65      8.3
  (Jacobi et al.,       1999
  2004)
  Health 2000           Finland            6 005   M-CIDI         DSM-IV           30+        3.4
  (Pirkola et al.,      2000
  2005)
  ESEMeD                6 European        21 425   WMH-CIDI       DSM-IV           18+        3.9
  (Alonso et al.,       countries
  2004)                 2000-2002
  NESARC                U.S.
  (Hasin et al.,        2001-2002         43 000   AUDASIS-IV     DSM-IV           18+        5.3
  2005)
  NCS-R                 U.S.               9 090   CIDI           DSM-IV           18+        6.6
  (Kessler et al.,      2001-2003
  2003)
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In  Finland,  the  Finnish Health  Care Survey  in 1996 reported a higher one-year prevalence
of MDE (9.3%) (Lindeman et al., 2000) than the Health 2000 project four years later
(Pirkola et al., 2005c). The differences may be explained by methodological factors
including differences in diagnostic interview and age frames (Pirkola et al., 2005c)
(Table 1.). Older age, marriage and employment predicted in Finland lower prevalence
(Pirkola et al., 2005c).
Dysthymic disorder has been scarcely studied in large surveys: one-year prevalence was
1.1% in the Australian National Survey of Mental Health and Well-Being (NSMHWB)
(Andrews et al., 2001) and current dysthymia was found in 1.5% of the U.S. general
population in ECA (Judd et al., 1997). In a Finnish computer-assisted telephone
interview a 6-month prevalence of dysthymia was about 2% (Isometsä et al., 1997).
4.4.1.2 Prevalence of subsyndromal depressive disorders 
The amount of depressive symptoms in the general population appears high (Cuijpers et al.,
2004). Reporting compatible prevalence rates, however, is difficult because of the high
variation in the criteria used for subsyndromal depressions or amount of minimum symptoms
required for inclusion in the available studies (Pincus et al., 1999). With use of the
definition in ECA, "two or more symptoms of depression and does not meet criteria of MDD,
dysthymia or MinD", 12-month prevalence of 8.4% and current prevalence of 3.9% were
obtained for subsyndromal depressive disorders in ECA (Judd et al., 1997). Judd has
suggested that two classes of subsyndromal depressive disorders exist in community: one,
which occurs as a component of the course of MDD; and another occurring spontaneously in
non-MDD subjects (Judd et al., 1994). In the first instance subsyndromal depression may
be prodromal to episodes of MinD or MDD or residual to resolving episodes (Judd et al.,
1994, Judd et al., 1997)
Lifetime MinD (2 to 4 symptoms of MDD without a lifetime history of either MDD or
dysthymia) was found in 10% of the respondents in the NCS (Kessler et al., 1997), one-year
MinD in 7.5% in the NEMESIS and current MinD in 1.5% in ECA (Judd et al., 1997).
4.4.2 Use of services for depression in population samples
Information about health service-use offered by epidemiological studies may increase our
capacity to assess how well recourses are allocated to meet treatment needs (Demyttenaere
et al., 2004). Evidence suggests that the majority of individuals with MDD receive no
treatment either in Finland or elsewhere (Demyttenaere et al., 2004, Hämäläinen et al.,
2004). The reasons for this are not well known. For exact analyses on help seeking
behaviour and on the factors relating to service-use, even large epidemiological surveys
often lack statistical power to disentangle differences in subgroups (Hämäläinen et al.,
2004).
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Although the majority of individuals with MDD consult their primary care doctors for
general health problems (Parikh et al., 1997), only about a third of them communicate
their depression to a health care professional (Parikh et al., 1997, Galbaud du Fort et
al., 1999, Hämäläinen et al., 2004, Wittchen et al., 2005).
The decision of seeking help seems to associate with higher disability and long-lasting,
severe symptomatology (Fortney et al., 1998, Hämäläinen et al., 2004, Hämäläinen et al.,
2008) such as suicidal thoughts (Galbaud du Fort et al., 1999) and co-morbid other
psychiatric disorders (Fortney et al., 1998, Galbaud du Fort et al., 1999), (Hämäläinen et
al., 2008) or co-morbid medical illnesses (Lin et al., 1998). Furthermore, attributing the
perceived distress to a mental health problem (Lin et al., 1998, Hämäläinen et al., 2004),
as well as personal attitudes such as feeling comfortable consulting a mental health
professional (Lin et al., 1998) may influence on help-seeking decision.
Even of those whose presenting complaint is depression, less than a half receive treatment
for it (Bebbington et al., 2000), and especially in primary care, the treatment is seldom
optimal (Bebbington et al., 1997). Although severity of depression correlates with
probability of treatment, from a third to two thirds of persons with serious depression in
developed countries, and more than three quarters in underdeveloped countries, receive no
treatment (Demyttenaere et al., 2004).
The majority of service-use is distributed among primary care services and specialist
services; of them primary care represents the basic level of health care system where
consumers may bring any heath problems - physical, mental, emotional or social at visits
to a general practitioner, family physician or company doctor. Specialty care in surveys
is usually defined as comprising the visits to a psychiatrist, psychologist, hospital
psychiatric emergency room, psychiatric outpatient clinic, mental health centre, drug or
alcohol outpatient clinic or inpatient drug clinic.
In epidemiological surveys individuals with MDD usually report having received treatment
twice as often in specialist care as in primary care (Alonso et al., 2004b, ten Have et
al., 2004, Hämäläinen et al., 2008), (Parikh et al., 1997). The choice of service provider
may be influenced by sociodemographic factors, such as age and educational background
(Parikh et al., 1997, ten Have et al., 2004, Hämäläinen et al., 2008), by the co-morbidity
and severity of depression and suicidal behaviour (ten Have et al., 2004), (Hämäläinen et
al., 2008) and also by the availability of services (Fortney et al., 1998).
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4.4.3 Public health impact of depressive disorders
Besides being a cause of human suffering, MDD is an important global public health issue;
depression was rated as the fourth leading cause of disease burden worldwide in 1990
(Murray et al., 1997b).
Depression has the tendency to assume a recurrent or chronic course, and over time to be
associated with increasing disability (Solomon et al., 2000, Andrews, 2001). Today in
Finland, depression is a major cause of permanent disability pension (Salminen et al.,
1997). Moreover, studies on family relationships have indicated significant impairment of
parental role in persons with depression (Goodman, 2007); children of depressed parents
are at a high risk for developing depression or other disorders themselves (Lieb et al.,
2002). Depression may even produce greater decrement in health compared with most chronic
diseases, such as coronary heart disease, arthritis, asthma, or diabetes (Hays et al.,
1995).
Death by suicide is the most important complication of depression. In Finland suicide is
the leading cause of death among those under the age of 35 years (Tilastokeskus, 2008).
Suicide also means a major loss of expected active life years and a huge stress and
long-term burden to the families of the victims of suicide. Moreover, attempted suicides
are one of the main causes for costly visits into emergency rooms of general hospitals
(Yeo, 1993).
The co-morbidity of depression with chronic physical diseases such as coronary heart
disease and diabetes is well recognized (Benton et al., 2007). The co-morbid state of
depression incrementally worsens health compared with depression alone, with any of the
chronic diseases alone and with any combination of chronic diseases without depression
(Benton et al., 2007). With a growing elderly population, and the associated increase in
prevalence of chronic medical conditions, a concomitant rise in the prevalence of
depression is to be expected. In fact, projections indicate that after heart disease,
depression is expected to become the second leading cause of disease burden by the year
2020 (Murray et al., 1997a).
These results indicate the urgency of addressing depression as a public health priority to
reduce disease burden and disability, and to improve the overall health of populations
(Moussavi et al., 2007).
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4.4.4 Prevalence of depressive disorders in clinical patient samples
4.4.4.1 Prevalence of depressive disorders in primary care and psychiatric care
The widest epidemiological clinical study so far on depressive disorders in primary care
has been the WHO PPGHC study in the mid-nineties (Sartorius et al., 1993), comprising 14
countries and 26 000 primary care patients around the world. In the prevalence of current
depressive disorders it found a 15-fold variation across countries (Simon et al., 2002)
(Table 2.). Whether the variation represents true differences in prevalences, it could
perhaps be caused by ethnic differences in vulnerability to depression and community-level
differences in exposure to stressors or traumatic events (Simon et al., 2002). The
variation may, however, represent problems with definition and measurement: the depressive
disorders defined in U.S. and Western Europe may exist in different forms in other
cultures, and identical diagnostic methods may identify different levels of severity of
depression due to linguistic or cultural differences in the tendency to report distress
(Mezzich et al., 1999).
In the WHO PPGHC an average of 10% of patients in primary care appeared to suffer from
current MDE and 2% from dysthymia based on ICD-10 taxonomy (Sartorius et al., 1996).
Comparable prevalences have been found in smaller studies (Olfson et al., 1996). In
Finland, the Tampere Depression (TADEP) Study found clinical depression in a tenth of
primary care patients; it also found clinical depression in one-half of patients in
community mental heath centres (Salokangas et al., 1996).
Patients seen in primary care often represent the less severe end of the disease spectrum.
They might be at the early stages of the illness, with less differentiated signs and
symptoms (Alegria, 2000) and therefore their depressive symptoms may fail to achieve the
diagnostic threshold for MDE or dysthymia. The prevalence of subsyndromal depressive
symptoms in a review of 36 primary care studies varied from 5% to 16% depending on the
definition of the condition (Pincus et al., 1999). The WHO PPGHC reported subsyndromal
symptoms (four symptoms of ICD-10 MDD criteria, one of which a core criteria) in 7% of
primary care patients (Sartorius et al., 1996); in a subsample, brief recurrent depression
lasting 3-4 days was found in 10% (Weiller et al., 1994). In a study comprising one
thousand primary care patients in U.S., 9% of individuals suffered from depressed mood or
anhedonia lasting at least two weeks (Olfson et al., 1996). In the Finnish TADEP study,
beside clinical depression, little less than 10% had some depressive symptoms (Salokangas
et al., 1996).
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     Table 2. Prevalences of ICD-10 Major Depressive Disorders 
in the study centres of the WHO Psychological Problems in 
      General Health Care study (Simon et al., 2002).
  City                Interviewed  N        Weighted prevalence   Confidence interval
                                              %                     95%
  Nagasaki                    336                    1.6                0.7-2.5
  Shanghai                    576                    2.5                1.6-3.4
  Ibadan                      269                    4.0                2.6-5.5
  Verona                      250                    4.6                2.9-6.3
  Berlin                      400                    5.3                3.9-6.7
  Seattle                     373                    6.4                4.6-8.2
  Athens                      196                    7.3                4.6-9.9
  Bangalore                   398                    8.6                6.1-11.1
  Mainz                       400                    9.9                6.6-13.1
  Ankara                      400                   10.7                7.7-13.7
  Paris                       405                   13.5                0.9-16.0
  Groningen                   340                   14.4               11.3-17.6
  Manchester                  428                   17.1               14.4-19.8
  Rio de Janeiro              393                   18.3               14.2-22.3
  Santiago                    274                   26.3               16.9-35.8
4.4.4.2 Prevalence of depressive disorders in medically ill patients
Depression frequently occurs in the context of chronic medical illness (Stein et al.,
2006), but only recent research in the community has attracted attention to the
relationship between depression and chronic medical conditions. A doubled risk of MDD in
medical conditions (e.g. migraine, sinusitis, back problems) was reported in medium term
follow-up in the Canadian National Population Health Survey (NPHS) (Patten et al., 2005,
Stein et al., 2006). Reports from general health care and specialist medical settings have
also described a high amount of co-morbid depression although the information of the
prevalences is inconsistent and suffers from selection bias (Alegria, 2000).
Of specific disease groups cardiovascular diseases have been an important focus of
depression research: in acute coronary artery disease the prevalence of MDD appears to be
from 15% to 23% (Glassman et al., 2002). Similar high prevalences of depression have been
found among post stroke patients (Robinson, 2003). Furthermore, chronic pain seems to
increase the risk of associating MDD the rate of which has been reported from 30% to 54%
(Baune et al., 2008).
33
Several explanations for the association of MDD and chronic medical conditions have been
proposed (Katon, 2003). Physical disease may cause depression either by biological or
psychological mechanism. One possibility is that depression may decrease the ability of
the individual to cope with limitations or symptoms (e.g. pain) imposed by the physical
illness. It is also possible that the loss of function and independence associated with
many chronic physical illnesses may cause depression.
4.5 Etiology and pathogenesis of depressive disorders
4.5.1 Multifactorial etiology
Depression is currently considered a complex, multifactorial disorder, where the risk
factors from multiple domains are related and interacting with each other (Kendler et al.,
2002, 2006). In the etiology of depression life stress appears an important component, but
also requires other vulnerability factors to explain onset conditions (Monroe et al.,
2001). A widely held view is that the combination of predisposing genetic factors, early
life stress and ongoing stress may ultimately determine individuals’ responsiveness to
stress and the vulnerability to depression (Charney et al., 2004). For better
understanding of the etiology and identifying the factors involved in the pathophysiology
and treatment of depressive illness, more has to be known about the genetic vulnerability,
neurochemistry, signal transduction mechanisms, neural circuits, psychosocial stressors
and their complex interaction. Moreover it has to be remembered that while diagnosed on
phenomenological basis, depression is likely to be an etiologically heterogeneous group of
disorders (Hasler et al., 2004).
4.5.2 Heritability
Depressive disorders and symptoms run in families (Sullivan et al., 2000, Lewinsohn et
al., 2003, Korszun et al., 2004). The heritability for depression is usually reported to
be from 30% to 40%, but the more severely depressed clinical samples have been
investigated the higher the heritability appears (McGuffin et al., 1996).
Slow progress in the genetic research on depression is anticipated while multiple genes
are possibly involved and interacting with environmental factors (Caspi et al., 2003). Of
special clinical interest are the candidate genes, which associate to the probability of
patients to respond to particular treatments such as the 5-HT transporter gene and its
allelic variation. An example of gene-by-environment interaction is Caspi’s finding that a
functional polymorphism in the promoter region of the 5-HT transporter gene moderates the
influence of stressful life events on depression (Caspi et al., 2003).
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4.5.3 Pathogenesis
The relationship between depression, modern antidepressant drugs and changes in levels of
serotonin and noradrenaline in the brain is usually greatly oversimplified when presented
to the public, at least partly due to the lack of specific scientific knowledge. Overall,
in the etiology of mood disorders and action of antidepressants, a major role has been
suggested for intracellular pathways regulating neuroplasticity and neurodegeneration
(Popoli et al., 2002). These relate in a complex way to multiple hormonal changes
including, among others, the disturbances in the regulation of corticotrophin releasing
factor (CRF) and functional disturbances in hypothalamic-pituitary-adrenal (HPA)-axis as
well as to brain-derived neurotrophic factor (BDNF) (Charney et al., 2004, Sapolsky, 2004,
Castren, 2005).
While many brain regions have been implicated in regulating emotions we still have poor
understanding of the neural circuitry underlying the normal mood or abnormalities of mood.
It is likely that several brain areas, documented in brain imaging studies to show
regional blood flow or metabolic changes, mediate diverse symptoms of depression (Nestler
et al., 2002, Mayberg, 2003).
4.5.4 Environmental risk factors
Environmental risk factors for depression can be divided into distant and recent risk
factors. The former include experiences from childhood and adolescence and the latter risk
factors, such as stressful life events and poor social support, occurring in a defined
period preceding the occurrence of MDE (Kendler et al., 2002, 2006).
4.5.4.1 Childhood experiences
The risk for adult MDD may be increased by a wide range of negative life events in
childhood ranging from sexual abuse (Heim et al., 2000), to a disturbed family
environment, such as poor parenting, parental loss or separation, and depression of
parents (Tennant, 1988, Lieb et al., 2002, Veijola et al., 2004). Individuals may react to
parenting and its shortcomings in different ways guided in part by genetically influenced
characteristics e.g. temperament (Kendler et al., 2006).
Within the Health 2000 study in Finland, the impact of adverse environmental factors
during childhood seemed to be composed of a wide range of factors from direct causal
associations to complex interacting environmental effects (Pirkola et al., 2005a). In
another Finnish study where depressiveness and childhood adversities alone and in
combination with recent adverse events were studied, the consequences of an unfavourable
childhood background seemed worse if combined with adult adverse life events (Korkeila et
al., 2005).
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4.5.4.2 Recent adverse life events and social support
Current stressful life events and difficulties form a major risk factor for MDD (Kendler
et al., 2006). Different types of difficulties may lead to different depressive symptom
profiles (Keller et al., 2007). Moreover, low social support appears to increase the risk
of recurrent MDE (Kendler et al., 2006). A bidirectional model has been suggested, where
partly genetically determined individual differences in personality appear to influence on
the way in which individuals view the world around them and on the likeliness of
experiencing stressful life events and on the quality of interpersonal relationships,
which in turn "feed back" to them, influencing their risk for depression (Kendler et al.,
2003). Of psychiatric patients often with complicated MDD, the majority attribute the
onset of MDE to some adverse event, although no clustering of live events appeared to
associate with the time of onset (Leskelä et al., 2004).
4.6 Course and outcome of depressive disorders
Research on the natural course of depressive disorders is essential for the understanding
of the nature of depression. Epidemiological studies support the view that depression is
dynamic in nature, evolving a continuum of depressive symptoms of varying severity and
duration, and that individuals in this continuum move in and out of various diagnostic
types of depression over time (Judd et al., 1997).
4.6.1 Methodological aspects in outcome studies
Interpreting reports on the course of depression and applying them to clinical practice
suffer from inconsistently used descriptors for change points in the course of the illness
(Frank et al., 1991, Keller, 2003). The terms in use across studies, such as relapse,
recurrence and especially remission, refer to a varying number and duration of symptoms,
despite the efforts taken to achieve a consensus on the terminology already in the early
nineties (Frank et al., 1991). Remission as a result of treatment has been proposed to be
defined as a completely asymptomatic state, with absence of all symptoms of depression and
functional impairment (Keller, 2003) as any residual symptoms serve as a strong predictor
of earlier relapse (Paykel et al., 1995, Judd et al., 1998) and impaired social
functioning (Kennedy et al., 2004). In a substantial part of research, patients have been
considered to be in remission despite exhibiting some minor symptoms (Keller, 1992). [In
this thesis the criteria of DSM-IV are used: relapse refers to the return of symptoms
fulfilling MDE criteria after a period of more than two weeks but less than two months
with symptoms below the MDE threshold, recurrence refers to the return of MDE after at
least two consecutive months of partial or full remission; the criteria for remission are
shown in figure 3.]
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Figure 3. DSM-IV criteria for Remission and Chronic Specifier for Major Depressive
Episode (APA, 1994). 
P a r t i a l  r e m i s s i o n
F u l l  r e m i s s i o n
C h r o n i c  M a j o r
 D e p r e s s i v e  E p i s o d e
D u r i n g  t h e  p a s t  2  m o n t h s ,  n o  
s i g n i f i c a n t  s i g n s  o r  s y m p t o m s  
o f  t h e  d i s t u r b a n c e  w e r e  p r e s e n t .
S y m p t o m s  o f  a  M D E  a r e  p r e s e n t
bu t  f u l l  c r i t e r i a  a re  no t  me t ,  o r  
t h e r e  i s  a  p e r i o d  w i t h o u t  a n y  
s i g n i f i c a n t  s y m p t o m s  o f  a  M D E  
l a s t i n g  l e s s  t h a n  2  m o n t h s  f o l l o w i n g  
t h e  e n d  o f  t h e  M D E .
Fu l l  c r i t e r i a  f o r  a  Ma jo r  
D e p r e s s i v e   E p i s o d e  h a v e  
b e e n  m e t  c o n t i n u o u s l y  f o r  
a t  l e a s t  t h e  p a s t  2  y e a r s .
Moreover, primary care studies suffer from reporting only a cross-sectional outcome of
depression i.e. reporting the status of the patient at the end of the follow-up period,
thus ignoring relapses and recurrences during the follow-up. This limitation has been
overcome in some studies on psychiatric patient populations, such as the NIMH-CDS (Keller
et al., 1987) and VDS in Finland (Melartin et al., 2004) with use of life-chart
methodology, based on multiple assessments during the longitudinal course of psychiatric
disorders in sufficient detail to provide the basis for calculating length of episodes and
time to remission (Keller et al., 1987).
4.6.2 Course and outcome of depressive disorders in population samples
In population surveys (ECA, NEMESIS, NCS-R) half of all MDEs resolve rapidly in two to
four months (Eaton et al., 1997, Spijker et al., 2002, Kessler et al., 2003) or even
faster (Hämäläinen et al., 2008), but in about one fifth of all individuals with MDD, the
course has been documented chronic (figure 3.)(Spijker et al., 2002). On the other hand,
among incident cases of MDD in a twin study, Kendler found that 98% of episodes resolved
within one year (Kendler et al., 1997).
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Recurrences have been documented in about 40% of individuals followed up for decades after
their first MDE (Mattisson et al., 2007); in retrospective analysis only a quarter
reported no earlier MDEs in NCS-R (Kessler et al., 1997). In population samples longer
time to remission or non-recovery have been consistently associated with higher severity
of depression and longer duration, that is, the longer a person is ill, the lower his or
her chances are of recovering (Keller, 1992).
4.6.3 Course and outcome of depressive disorders in primary health care
Though prognosis clearly serves the planning of treatment, in only few studies does the
follow-up time exceed one year and only cross-sectional outcomes are reported. The course
of depression has been followed with life-chart methodology in only one study in primary
care; there the median duration of eight months was found in acute episodes of depressive
disorders and 91% of MDE reached at least partial remission during 42 months follow-up
(Oldehinkel et al., 2000). In cross-sectional outcome studies, full recovery in one year
has been reported in a quarter to one-half of patients and chronic course in a third of
patients (Ormel et al., 1993, Gaynes et al., 1999, Wagner et al., 2000, Lyness et al.,
2002, van den Brink et al., 2002, Barkow et al., 2003, De Almeida Fleck et al.,
2005)(Table 3). In MDD recurrent course has been suggested in one-half of patients in
medium-term follow-up (Oldehinkel et al., 2000). Altogether, up to one-fifth of
subsyndromal depressive symptoms seem to proceed to MDE in one year (Wagner et al., 2000,
Lyness et al., 2002).
The clinical predictors of outcome in depressive disorders are not well known in primary
care. In observational studies predictors of time to remission or recurrence have not been
investigated. On cross-sectional outcome co-morbid Axis I disorders have had an adverse
impact in many studies (Ormel et al., 1993, Gaynes et al., 1999, Burns et al., 2000, van
den Brink et al., 2002, Barkow et al., 2003, De Almeida Fleck et al., 2005); among
elderly, medical illnesses have served as a powerful predictor of the outcome (Lyness et
al., 2002).
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  Table 3. Observational outcome studies in primary care with medium-term follow-up.
                                 Baseline                                                              Follow-up
  Source           Major           Screening     Method of     Duration      Co-morbid     Months of     Method        Outcome
                   depression N                  assessing     of            Axis          follow-up     of
                   /Subsyndromal   Diagnostic    severity of   episode/      I/II/III                    diagnosing
                   depression N    methods       depression    recurrence    disorders     Life-chart    outcome
                                                               assessed      assessed      if used
                   age range
  De Almeida       968/-           CES-D;        CES-D         -/Yes         I / - / III   9             CIDI and      Full remission 35% at 9 months
  Fleck et al.,                    acute                                                                 CES-D
  2005             18-75           and/or                                                                >16
                                   untreated
                                   depression
                                   CIDI
  Barkow et al.,   725/-           GHQ-12        Mild,         Yes/-         I / - / III   12            CIDI-PHC      Major depression 34% at
  2003                                           moderate or                                                           12 months
                   18-65           CIDI-PHC      severe
                                                 depression
  van den Brink    269/-           GHQ-12        Number of     Yes/Yes       I / - / III   12            CIDI-PHC      No recovery 29% at 12 months
  et al.,                                        depressive
  2002             18-65           CIDI-PHC      symptoms
  Lyness et al.,   22/41           CES-D         HAM-D         -/-           - / - / III   12            SCID-I        Major depression 12%
  2002                                                                                                                 Subsyndromal depression 44%
                   >59             SCID-I                                                                              Full remission 43% at 12 months
  Wagner et al.,   66/75           CES-D         CES-D         -/-           I / - / III   12            Telephone     Major depression 30%
  2000                                                                                                   DIS           Subsyndromal depression 24%
                   18-64           Telephone                                                                           Full remission 46% at 12 months
                                   DIS
  Oldehinkel       54/32           30-GHQ;       PSE score     Yes/-         - / - / -     42            PSE           At least partial remission
  et al.,                          acute                                                                               from index episode 93%
  2000             17-65           depression                                              and                         in median 8 months
                                                                                           life-chart
                                   PSE
  Gaynes et al.,   85/-            CES-D         CES-D         -/-           I / - / III   12            Telephone     Major depression 44%
  1999                                                                                                   DIS           Subsyndromal depression 25%
                   18-64           Telephone                                                                           Full remission 29% at 12 months
                                   DIS
  Ormel et al.,    52/27           30-GHQ;       Major         -/-           I / - / -     42            PSE           Major depression 12%
  1993                             acute         depression/                                                           Subsyndromal depression 25%
                   17-65           depression    Subsyndromal                                                          Full remission 63% at 42 months
                                                 deprression
                                   PSE
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4.6.4 Course and outcome of depressive disorders in psychiatric care
Compared  to  primary  care, reports  on  course  and  outcome  from  psychiatric settings are
abundant, and the overall picture of clinical depression has mostly been based on studies
there.
Though achieving total remission in MDD has lasted a median of 11 months (Holma et al.,
2008), already after 3 months (Furukawa et al., 2000) to 6 months (Keller, 1992) only
some minor residual symptoms have existed. Residual symptoms are common (Melartin et al.,
2005), especially after initially severe depression (Paykel et al., 1995), and they may
persist for years (Judd et al., 1998) even with antidepressant treatment (Kennedy et al.,
2004).
Moreover, a chronic course has been found in about one-tenth of patients (Holma et al.,
2008a) or even in a higher percentage among inpatients (Keller, 1992). Poor prognosis has
been consistently associated with longer duration or higher severity of depression and
co-morbid dysthymia (Ramana, 1995, Parker, 2000, Solomon et al., 2000, Meyers et al.,
2002, Melartin et al., 2004, Holma et al., 2008). Patients with current alcoholism in
NIMH-CDS were only half as likely to recover from their MDE as those without (Mueller et
al., 1994). Co-morbid chronic medical condition may in specialist care have only a minor
effect on recovery from depression (Viinamäki et al., 2000).
A high number of recurrences of MDE have been documented in specialist care (Mueller et
al., 1999, Viinamäki et al., 2002, Kennedy et al., 2003, Melartin et al., 2004, Holma et
al., 2008). Approximately eight out of ten patients may experience more than one MDE
during their lifetime (Mueller et al., 1999), the risk increasing hand in hand with the
severity of depression (Ramana, 1995). Other reported risk factors of recurrences have
been residual symptoms after recovery (Paykel et al., 1995, Judd et al., 1998), prior
recurrences and relapses, long duration of current depression (Mueller et al., 1999) and
co-morbid cluster C-personality disorders (Holma et al., 2008).
In specialist care, sociodemographic factors appear to have no significant effect on the
outcome of MDD when depression severity and level of functional status are controlled for
(Wells et al., 1992, Mueller, 1996).
40
4.7 Co-morbidity of depressive disorders
4.7.1 The concept of co-morbidity
Co-morbidity refers to the occurrence of two or more distinct disorders at the same time
in an individual. Four main categories are apparent in co-morbidity (Robertson et al.,
1997):
1) Coincidence of two illnesses, e.g when a psychiatric illness appears unrelated to a
physical illness.
2) One disorder is a risk factor to another, e.g. depression may serve as an independent
risk factor for ischemic heart disease in men (Hippisley-Cox et al., 1998).
3) Both illnesses have a common cause; either hereditary factors or environmental factors
may have predisposed to both. E.g. generalized anxiety disorder (GAD) and MDD have shared
genetic backgrounds but different environmental risk factors (Middeldorp et al., 2005).
4) One disease is the cause of another. Physical disease may cause psychiatric disorder
either by biological or psychological mechanism. The difficulties in judging whether
biological processes contribute to the aetiology of a psychiatric disorder has been
recognized in DSM-IV; there "mood disorder due to general medical condition" include
classification on the basis of the mood symptoms but with an extra code to indicate
co-morbid physical illness (APA, 1994). [In the studies of this thesis, patients with mood
disorders due to general medical conditions have been excluded.]
4.7.2 The mechanisms of co-morbidity in depression
The concept of co-morbidity has been introduced to psychiatry along the operational
diagnostic system for mental disorders (APA, 1980). Co-morbidity of two or more
psychiatric disorders has, however, been criticized for being an artefact produced by the
categorical diagnoses, which are unable to differentiate disorders according to its
pathogenesis or ethiology (Wittchen, 1996, Maj, 2005).
Growing evidence suggest that a vast majority of co-morbid depressive disorders occur
secondary to other mental disorders, most often anxiety (Kessler et al., 1996, Wittchen et
al., 2000). The presence of an anxiety disorder seems to be the single highest clinical
risk factor for the development of depression (Wittchen et al., 2000). A common scenario
appears to be the following: exposure to significant life stressors such as interpersonal
conflict, some type of personal loss or some type of life threat leads to clinical levels
of anxiety.Thereafter, the experience of anxiety may in turn serve as a compounding
stressor that facilitates further decompensation, leading in patients, especially in those
with genetic or familial diathesis, to MDD (Hirschfeld, 2001).
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Within individuals with co-morbid depression and substance use, multiple pathways of
association may act simultaneously. The combination of shared diathesis and causal models
(in both directions) may explain why the association of depression with drugs or alcohol
dependence does not show any unidirectional pattern (Swendsen et al., 2000).
The causal relationship between personality disorders and MDD is unclear; two commonly
proposed explanations are the "vulnerability" model, where certain personality traits
serve as risk factors for the development for depression (Shea et al., 1996) and the
"scar" model suggesting that a depressive episode is the cause of a permanent change in
the personality.
Among elderly primary care patients, medical illnesses serve as a frequent precipitant of
depressive conditions (Lyness et al., 2002). A hypothesis has suggested that the
association may be either multimodal or involve a final common pathway that includes
elements common to many diseases, e.g. the potential role of inflammatory cytokines, or
common psychosocial factors or altered social-role functioning (Lyness et al., 2002).
4.7.3 Methodological aspects in research on co-morbidity
Depressive disorders seldom present in pure forms even in population samples (Kessler et
al., 2003). Across studies there is, however, in the magnitude of co-morbidity
substantial variation at least partly due to methodological incompatibilities in terms
diagnostic assessments, timing of diagnosing, time frame (e.g. lifetime or current), and
health care settings (Wittchen, 1996) to mention a few.
Moreover, the significance of co-morbidity in the clinical picture, course and outcome of
depression often remains unclear. The effect of overall co-morbidity on the length of
episode or risk of recurrence has rarely been systematically investigated (Melartin et
al., 2002), and available studies mainly focus on a single type of co-morbid disorder.
Most studies have not used semistructured or structured interviews for both MDD and
co-morbid disorders, controlled for the effects of additional co-morbid disorders nor used
life-chart methodology, but rather only report cross-sectional findings.
4.7.4 Psychiatric co-morbidity of depressive disorders in population samples
Bearing in mind the methodological limitations, population surveys suggest that co-
morbidity in MDD is more a rule than an exception. In NCS-R only one-fifth of individuals
with 12-month MDD did not have a 12-month Axis I co-morbid DSM-IV disorder; 58% had
anxiety disorder and 9% had substance use disorder (Kessler et al., 2003). In Finland, a
third with anxiety disorder and a tenth with alchohol use disorder were found (Pirkola et
al., 2005c). In NESARC, at least one personality disorder was present in 46% of
individuals with 12-month MDD, most often obsessive-compulsive or paranoid personality
disorder; among those with dysthymia, personality disorders were even more prevalent (55%)
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(Grant et al., 2005). In the Zurich Cohort Study among individuals with current
subsyndromal depressions, a third suffered from a diagnostic or subthreshold anxiety
disorder (Preisig et al., 2001).
4.7.5 Psychiatric co-morbidity of depressive disorders in primary care patients
Among primary care patients with MDD, psychiatric co-morbidity is highly prevalent. In the
WHO PPGHC study, 62% of the patients with current MDD also had another psychiatric
diagnosis (Wittchen et al., 1999). For co-morbid anxiety disorders, prevalence rates of
23% to 50 % have been reported (Coyne et al., 1994, Sartorius et al., 1996, Sherbourne et
al., 1996, Gaynes et al., 1999, Lenze et al., 2000), and for co-morbid substance use
disorders, from 6% to 33% (Coyne et al., 1994, Roeloffs et al., 2001). The prevalence of
Axis II co-morbid disorders has only been reported from a few treatment intervention
studies, which are unlikely to be representative of patient populations in primary care
(Patience et al., 1995, Brown et al., 1996, Ekselius et al., 1998). Among primary care
patients with subsyndromal depressive disorders a third may have psychiatric co-morbidity:
anxiety disorders have been found in 16% (Coyne et al., 1994) and substance use disorder
in 9% (Olfson et al., 1996).
4.7.6 Psychiatric co-morbidity of depressive disorders in psychiatric patients
The majority of research on co-morbidity in MDD has been conducted in psychiatric
settings. The full Axis I and Axis II repertoire has been investigated among patients in
secondary level psychiatric care in the Vantaa Depression Study (VDS); the reported
prevalences of current co-morbid anxiety disorders were 57%, substance use disorders 25%,
and, personality disorders 44% (Melartin et al., 2002). The co-morbidity tended to
cluster in the same patients. In patients with subthreshold depression, the overall
co-morbidity has been reported similar to those with MDD except for a smaller amount of
anxiety disorders (Sherbourne et al., 1994).
4.7.7 Medical co-morbidity of depressive disorders
A bidirectional relationship has been observed between depression and medical illnesses:
compared to the general population those with chronic illnesses often have much more
co-morbid depression (Cassem, 1995). Depression also serves as an independent risk factor
for some medical illnesses, such as cardiovascular disease, epilepsy and stroke
(Hippisley-Cox et al., 1998, Evans et al., 2003). Furthermore, depression may promote
adverse health behaviours such as smoking, unhealthy diet, sedentary lifestyle and poor
adherence to medical regimens (Katon, 2003) which may serve as risk factors for medical
illnesses.
In the WHO PPGHC study, the risk of co-morbid medical illness was 2.5 times higher in
patients with MDD than in non-depressed patients; e.g. observed coexistence of coronary
heart  disease  and  depression  has  been  higher than  expected by chance (Maier et al., 1999).
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The prevalence of chronic somatic diseases in patients with MDD has been found between 60%
and 80% (Coulehan et al., 1990b, a, Koike et al., 2002). Moreover, in patients with MDD
physical illnesses have appeared more severe than in non-depressed patients (Coulehan et
al., 1990b) as well as, in them, complaints of disabling pain have appeared more frequent
(Arnow et al., 2006).
In IMPACT study, elderly patients with MDD or dysthymia had about four co-morbid chronic
somatic illnesses each (Harpole et al., 2005); depression, however, had the most impact on
their well-being (Ormel et al., 1998).
4.7.8 The impact of co-morbidity of depressive disorders
In the research on co-morbidity in depression, most attention has been given to anxiety
disorders. Besides the adverse impact on course and outcome, it has been shown to increase
the severity of depression and cause greater impairment in work functioning, psychosocial
functioning and quality of life than in patients without co-morbid anxiety (Brown et al.,
1996, Olfson et al., 1997, Kessler et al., 1998, Roy-Byrne et al., 2000). Moreover,
co-morbid anxiety has been shown to significantly increase the suicide attempt risk above
what is contributed by MDD alone (Kessler et al., 1998); rates of suicide attempt are
suggested to be 70% higher in patients with co-morbid MDD and panic disorder than in those
with MDD alone (Roy-Byrne et al., 2000). On the other hand, the coexistence of anxiety
disorder with depression seems to enhance help-seeking (Roy-Byrne et al., 2000).
Co-morbid physical illnesses influence on presentation and recognition of depression in
primary care thus forming a barrier against adequate care (Simon et al., 1999b). Moreover,
concurrent physical symptoms appear to influence on severity and symptom patterns of MDD
(Yates et al., 2004).
According to natural and treatment studies of depressed patients with and without
arthritis, chronic obstructive pulmonary disease, diabetes or heart disease, depression
significantly increases the functional impairment in medical illness (Simon, 2003) and
contributes to the economic burden of the medical illness; medical costs for patients with
MDD are approximately 50% higher than the costs of chronic medical illness alone (Simon,
2003).
Treatment guidelines suggest co-morbidity patterns taken into account in the choice of
treatment modality (AHCPR, 2000). The overall impact of co-morbidity on treatment response
remains however, obscure, as various types of co-morbidity may have a very different
impact. The effect of co-morbid psychiatric disorders on treatment response in
intervention studies varies. According to some studies, neither co-morbid anxiety
disorders nor personality disorders had any major effects on treatment responses in
psychiatric care (Mulder, 2002, Krishnan, 2003), whereas concurrent medical illness
predicted worse treatment outcome in depression in another study (Iosifescu et al., 2003).
In primary care interventions co-morbidity has associated with poorer treatment response
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(Brown et al., 1996), on the other hand, e.g. IMPACT study has shown that elderly
individuals with medical co-morbidity seem to respond to treatment similarly to those
without any medical co-morbidity (Harpole et al., 2005).
Overall, co-morbidity of another disorder in depressive disorders quite constantly seems
to cause more functional impairment, higher economical costs in health care and higher
utilization of medical services (Sherbourne et al., 1996, Hirschfeld, 2001, Rytsälä et
al., 2006).
4.8 Suicidal behaviour
4.8.1 Classification of suicidal behaviour
The concept of suicidal behaviour ranges from suicidal ideation to suicide attempts and
completed suicide and it may vary with respect to manifestation, performance, seriousness
and lethality (Beck, 1986).
Suicidal ideation is usually defined as thoughts and wishes of suicide in individuals who
have not made any overt suicide attempts (Beck, 1986). Suicidal ideation includes suicide
threats, suicidal preoccupations and expressions of the wish to die as well as indirect
indicators of suicide planning. Suicidal ideation appears to be an important marker for
identifying patients at risk of suicide (Brown et al., 2005).
Suicide attempt is defined by APA as a self-injurious behaviour with a non-fatal outcome
accompanied by evidence (either explicit or implicit) that the person intended to die
(APA, 2003), where intent is defined as subjective expectation and desire for a
self-destructive act to end in death (APA, 2003). Suicide attempt may be replaced by other
terms in research literature, such as deliberate self-harm which in the U.K. is used for
all episodes of survived self-harming behaviours regardless of intent. In North America
deliberate self-harm usually refers to repetitive suicidal behaviour (Skegg, 2005), but
not for overdoses or if methods of high lethality have been used.
Suicide is defined as a self-inflicted death with evidence (either explicit or implicit)
that the person intended to die (APA, 2003).
4.8.2 Stress-diathesis model
Suicidal behaviour usually presents with a psychiatric disorder. While most psychiatric
patients never attempt suicide, additional risk factors are, however, required. To better
explain the process and risk for suicidal behaviour a stress-diathesis model has been
proposed (Mann, 2002). The diathesis in the model is understood as a predisposition which
may affect the threshold for suicidal behaviour when a stressor is present. The diathesis
consists of enduring conditions or traits such as hopelessness and increased lifetime
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impulsivity that may be related to specific impairment of serotonergic input into the
ventral prefrontal cortex (Mann et al., 1999). Among the many types of triggering
stressors, the onset or acute worsening of psychiatric disorder is nearly always present
in suicide attempters (Mann, 2002). In the model, at least one major risk factor from both
stressors and diathesis must be present to form high risk for suicide (Mann, 2002).
4.8.3 Epidemiology and risk factors of suicidal ideation
Suicidal thoughts are common; approximately 11-18% in population samples across Western
countries report having experienced suicidal ideation at some point during their life
(Weissman et al., 1999), but worldwide, huge differences exist in reported prevalence
rates across countries: from 3% to 25% of population have experienced suicidal ideation
and from 1% to 16% have made suicide plans (Weissman et al., 1999, Bertolote et al., 2005,
Bernal et al., 2007). Some of the differences across the sites are most probably affected,
beside the various ways of asking about suicidal ideation, by the differences in the
willingness of respondents from different cultures to report suicidal thoughts (Bertolote
et al., 2005).
In U.S., large population surveys (NCS, NCS-R) report 12-month prevalence of suicidal
ideation to be around 3 % and of suicide plans to be around 1% (Kessler et al., 2005a). In
Slovenia, a country of high suicide mortality (Schmidtke, 1997), 22% of the general
population acknowledge having had suicide thoughts during the last year (Kocmur et al.,
2003). In the Finnish study the 12-month prevalence was 15% - contrary to most other
countries, in Finland the prevalence was higher in men than in women (Hintikka et al.,
2001).
Suicidal thoughts in clinical patient samples are more frequent than in the general
population. Even in primary care, persons with suicidal thoughts are many times more
likely to visit their care doctor than those without suicidal thoughts (Goldney et al.,
2001). Suicidal ideation could be obtained in about 9% of unselected primary care patients
in a self-report questionnaire (Goodwin et al., 2003). In Australia, 6 % of elderly
primary care patients acknowledged current suicidal ideation (Pfaff et al., 2006).
However, about half of individuals experiencing suicidal thoughts do not perceive the need
for care, and of those who do, many experience difficulties in obtaining it (Brook et al.,
2006).
The most consistently identified risk factors of suicidal ideation have been depression
and hopelessness (Hintikka et al., 2001, Casey et al., 2006). Moreover, suicidal ideation
has been related to younger age, female gender and a low level of education (Kessler et
al., 2005a, Bernal et al., 2007). Protective factors have been getting older and having
meaningful social relations (Casey et al., 2006).
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4.8.4 Suicidal ideation in patients with depressive disorder
While depression is a major risk factor for suicidal ideation, it is not unexpected that
among patients with MDD, more than a half in psychiatric settings (Sokero et al., 2003)
and a third in primary care have reported suicidal ideation (Ahrens et al., 2000). In a
thorough Finnish study, independent risk factors have been hopelessness, alcohol problems,
low level of social and occupational functioning and poor received social support among
psychiatric in- and outpatients with MDD (Sokero et al., 2003). Other reported risk
factors consist of severe depression, and co-morbid dysthymia, anxiety and personality
disorders (Van Gastel et al., 1997, Hintikka et al., 1998, Alexopoulos et al., 1999,
Schaffer et al., 2000), as well as female gender, younger age and severe adverse life
events (Schaffer et al., 2000, Monroe et al., 2001, Casey et al., 2006). Previous suicide
attempts also predict suicidal ideation (Alexopoulos et al., 1999).
4.8.5 Epidemiology and risk factors of suicide attempt
Official suicide attempt rates are not available in most countries. The WHO/EURO
Multicentre Project on Parasuicide has gathered comparable information in 13 European
countries in 1989-1992: the highest rate of suicide attempts among males was in Finland
and the lowest in Spain, representing a 7-fold difference (Schmidtke et al., 1996). Around
the world even higher variation across nations has been reported (from 0.4% to 4.2%)
(Bertolote et al., 2005). A part of the variation may be explained by different cultural
attitudes towards suicidal behaviour and by the willingness to report suicide attempts
(Schmidtke et al., 1996). There are indications that, depending on the site, the ratios
between attempts, plans and thoughts of suicide differ substantially and that the burden
of undetected attempted suicide is high in many cultures (Bertolote et al., 2005).
In the WHO/EURO Multicentre Project on Parasuicide more than half of the suicide
attempters made more than one attempt, it has been reported that nearly 20% of the second
attempts were made within 12 months of the first attempt (Schmidtke et al., 1996). Nearly
all suicide attempters have suffered from one or more psychiatric disorder (Suominen et
al., 1996, Kessler et al., 2005a). In WHO/EURO Multicentre Project on Parasuicide, with
only one exception (Helsinki), suicide attempt rates were higher among women than men. In
the majority of centres, the highest rates were found in the younger age groups. Risk for
suicide attempts has also been related to being divorced or widowed, and to low
educational level (Kessler et al., 1999b).
Though nearly 2% of those who harm themselves may die within the following year by suicide
(Owens et al., 2002), the aftercare in medical emergency units appear varying and
insufficient (Kapur et al., 1999): only about half of suicide attempters have received
psychosocial assessment and in most studies only few get admission to psychiatric services
(Kapur et al., 1999, Suominen et al., 2004b). In a Finnish study, half of young suicide
attempters failed to have any health care contact in the month following the visit at the
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emergency unit (Suominen et al., 2004b), while most elderly suicide attempters, however,
were referred for aftercare mainly to psychiatric services (Suominen et al., 2004a).
Furthermore, in a study by Haw, where the majority of patients were offered treatment in
psychiatric services, only a minority stayed in contact (Haw et al., 2002). Also most
suicide attempters have not communicated their suicidal thoughts, even though the majority
have had recent contact with medical services (Houston et al., 2003).
4.8.6 Suicide attempts in patients with depressive disorders
A suicide attempt, especially if followed by death, is the most important complication of
depression. Of individuals with a lifetime diagnosis of MDD, 16% acknowledged having
attempted suicide at some point in their lifetime in ECA survey (Chen et al., 1996); the
first suicide attempt seems to occur within 5 years from the onset of MDD in 40% of
patients with depression (Malone et al., 1995a). One quarter may repeat the attempt within
a year (Bradvik, 2003).
Independent predictors, reported by Sokero et al. (2003), for suicide attempts among
psychiatric in- and outpatients with DSM-IV MDD are severity of depression and alcohol
dependence or abuse in particular; also younger age and a low level of social and
occupational functioning were risk factors (Sokero et al., 2003).
Others may be hopelessness, impulsiveness (Maser et al., 2002), co-morbid personality
disorder (Hawton et al., 2003), recent adverse life events and marital problems (Malone et
al., 1995a, Oquendo et al., 2006). A prior suicide attempt serves as a significant
indicator of risk (Oquendo et al., 2006). In clinical risk factors there appears to be
some gender related differences (Oquendo et al., 2007): e.g. in women the importance of
past suicidal behaviour is higher, each past suicide attempt increases the future risk
threefold (Oquendo et al., 2007).
Despite its clinical importance, not all depressed patients at the time of the suicide
attempt are receiving treatment or adequate pharmacotherapy (Oquendo et al., 2002). Haw et
al. (2002) found that one third of attempters were receiving treatment for depression in
psychiatric services and another in primary care (Haw et al., 2002). In a Finnish study
the majority of elderly suicide attempters had had recent contact with primary care, but
their mood disorders had often remained undiagnosed before the attempt (Suominen et al.,
2004a). Even in psychiatric hospitals a fourth of clinicians may fail to document the
history of suicidal behaviour in patients with MDD and past suicidal attempts (Malone et
al., 1995b).
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4.8.7 Epidemiology of suicide
Suicide is an important course of mortality accounting for 887 000 deaths every year (WHO
2003). Rates of suicides vary greatly across countries (Schmidtke, 1997), at least partly
due to transcultural differences in age structure and socioeconomic factors, the influence
of race and ethnicity and the impact of religion, to mention a few (De Leo, 2002, Oquendo
et al., 2004).
The official rates depend, moreover, on legislation of suicide, the death certification
procedures (Schmidtke et al., 1996) and prevalence of undetermined deaths (Marusic et al.,
2003). Everywhere in the world, suicide rates among males are manifold higher than in
female for all age groups (Schmidtke et al., 1996). The Finnish suicide rate is among the
highest in Europe (altogether 1062 in 2006) (Tilastokeskus, 2008).
4.8.8 Risk factors of suicide
What drives individuals to take their own life remains unanswered despite numerous
studies. The major obstacle to an understanding of suicide is that the victim cannot be
interviewed and the reason directly ascertained. Psychological autopsy is probably the
most direct technique for determining the relationship between particular risk factors and
suicide (Isometsä, 2001, Cavanagh et al., 2003).
Psychiatric disorders, present in nine out of ten suicide victims (Arsenault-Lapierre et
al., 2004), are the most significant predictors of suicide risk (Cavanagh et al., 2003)
especially when necessitating hospital admission (Bostwick et al., 2000, Mortensen et al.,
2000, Pirkola et al., 2005b). Particularly vulnerable periods seem to occur during
admission and soon after discharge (Mortensen et al., 2000). In the majority of suicides
more than one psychiatric illness has been present, most frequently affective disorders
especially among women and substance use disorders in men (Cheng et al., 2000, Cavanagh et
al., 2003, Arsenault-Lapierre et al., 2004) (Henriksson et al., 1993, Mann et al., 2006).
Medical illnesses increase the risk for suicide (Koponen et al., 2007) especially in the
elderly and in patients suffering from disorders of the central nervous system (Breslau et
al., 1991). In other potentially fatal illnesses, such as cancer, the increase in risk is
only modest unless a combined psychiatric disorder is present (Henriksson et al., 1995).
Hopelessness, defined as a state of negative expectations, is an important psychological
variable of suicidal behaviour which is believed to mediate the association between
depression and suicidal behaviour (Beck et al., 1993). Whether it leads to suicidal
behaviour depends upon the presence or absence of risk and protective factors (Beck et
al., 1993).
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Psychosocial and other environmental factors influencing on the risk of suicidal death are
male gender, advancing age (Hawton et al., 2003), lack of social network, recent adverse
life events and socioeconomic difficulties (Cheng et al., 2000, Suokas et al., 2001).
Other suggested risk factors of suicide are availability of lethal methods such as
domestic coal gas, barbiturates and firearms (Oliver et al., 1972, Kreitman, 1976,
Wintemute, 1988), and suicide stories of high publicity (Hassan, 1995).
A family history of suicide has been shown to increase the the risk for suicide in other
family members (Brent et al., 1996, Cheng et al., 2000).
Past suicidal behaviour, both ideation and attempts, are strong risk indicators for future
suicide (Brown et al., 2000). Within the year following a suicide attempt, the risk of
eventual death by suicide is about 100 times greater than that of the general population
(Hawton, 1987). Suicides seem to accumulate even years after an attempt (Suominen et al.,
2004c). It has been postulated that a lifetime history of suicide attempts can lower the
threshold of new attempts and thus suicide related structures may become more easily
triggered (Joiner et al., 2000). It has to be remembered, however, that over half of
suicide victims die at their first suicide attempt, according to Isometsä and Lönnqvist
(1998), and thus even if a suicide attempt is a powerful single predictor of completed
suicide, its sensitivity as a risk factor is limited (Isometsä et al., 1998).
4.8.9 Depressive disorders and completed suicide
A highly quoted meta-analysis of Guze & Robins (1970) suggested that 15% of psychiatric
patients with severe affective disorders will die of a suicide (Guze et al., 1970).
Thereafter this high figure has been uncritically generalized to concern all depressive
disorders and not until lately been debated and reassessed.
Bostwick & Pankratz (2000) have demonstrated a hierarchy of risk based on the intensity of
the treatment setting; they found a lifetime risk of 4.0% for suicide in their
meta-analysis for affective disorder patients hospitalized without specification of
suicidality (Bostwick et al., 2000). Furthermore, suicide mortality among depressed
patients in primary care has been shown to be much lower than in psychiatric settings
(Simon et al., 1998).
In patients with depression the risk factors for completed suicide tend to overlap the
general risk factors for suicide. They include male gender (Hoyer et al., 2004),
hopelessness (Coryell et al., 2005) and adverse life events (Mann et al., 2005b). Co-
morbid psychiatric disorders have often been present, such as substance use disorder and
personality disorder (Dumais et al., 2005, Gonda et al., 2007, Oquendo et al., 2007).
Especially in depressive men, impulsive-aggressive personality and alcohol disorders may
be independent risk factors (Dumais et al., 2005). In depressed patients prior suicidal
behaviour (Oquendo et al., 2006) and previous psychiatric hospitalizations also indicate
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risk of suicides. In non-psychiatric patients with depression the suicidal intent has
usually not been communicated to health care professionals and the depression has remained
untreated (Isometsä et al., 1995).
4.8.10 Prevention of suicidal behaviour
Given the rarity of completed suicides even in highrisk populations, many individuals need
to be targeted in order to prevent few suicides. To address the multiple causes of
suicidal behaviour, prevention strategies usually involve a multifaceted approach with
particular attention to mental health.
Primary prevention of suicide requires focusing on preventive measures or protective
factors such as restricting access to lethal methods (firearms, pesticides, toxic gas,
barbiturates etc.), which is a major component of current international suicide prevention
strategies (WHO), the toning down of reporting of suicides in the media and public
education campaigns to increase knowledge on mental illness and suicide (Mann et al.,
2005a).
Secondary prevention options include early detection of suicidal individuals as well as
accurate diagnosis and effective treatment of psychiatric disorders - another major
component of international prevention strategies (WHO). While more than half of those who
die by suicide had recently contacted a primary care doctor (Luoma et al., 2002) detection
of their suicidal intent might have been possible in some cases.
Despite their importance for planning, the relative impact of various strategies on
national suicide rates has been difficult to estimate. In a recent systematic review (Mann
et al., 2005a) physician education, means restriction and gatekeeper education have been
the most promising interventions. Public education campaigns have increased knowledge and
improved attitudes toward mental illness and suicide, but measures for suicide prevention
have been insufficient (Mann et al., 2005a).
Studies examining suicidal behaviour in response to primary care physician education
programs, mostly targeting depression recognition and treatment in limited regions in
Sweden, Hungary, and Japan (Rihmer et al., 1995, Oyama et al., 2006, Szanto et al., 2007),
have all reported an increased prescription rate of antidepressants and often a decline in
suicide rates.
Despite the huge burden caused by suicide mortality, the number of national policies for
preventing suicides is low; Finland published, the first country worldwide, a national
strategy of suicide prevention and an action plan for implementation in 1991. It was a
part of the National Suicide Prevention Project, which was carried out from 1986 to 1996.
The aim was to stop the increasing trend and decrease suicide mortality by 20% by the year
1995. During the first years the number of suicides increased, followed by a reduction of
20% between 1991 and 1996, since then the suicide rate has decreased steadily and the
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annual amount of suicides has declined to below 1000 (Lönnqvist, 2007). However, Finland
still has a relatively high suicide rate compared with other Western EU countries
(Schmidtke, 1997), suicide being the leading cause of death in Finland among those under
the age of 35 years (Tilastokeskus, 2008).
4.9 Treatment process in primary care
4.9.1 The pathways to care
Goldberg and Huxley have suggested a framework for understanding the pathways by which
individuals become defined as mentally ill and by which they eventually reach a mental
health specialist (Goldberg et al., 1980). They introduced five levels (1) community, 2)
primary care with total load of mental illness, 3) primary care with detected mental
illnesses, 4) specialist mental health services, and 5) inpatients) and four "filters"
through which patients have to pass to reach the next level. The first filter consists of
a person’s interpretation of signs of distress (either physical or psychological) as an
illness. Guided by this interpretation the person may seek help by consulting a primary
care doctor and thus move to the next level. The second and third filters in primary care
concern detection, diagnostics and referral. The fourth filter in specialist services
concerns admission.
Passing the first filter, with any presenting complaints either somatic or psychosocial,
provides the primary care level with opportunities to promote health and prevent disease
(Üstün, 2000). The second filter, however, has to be passed in order to receive treatment
for depression. The permeability of the third filter reflects the allocation of resources
and responsibilities in the particular health care system and the fourth filter concerns
allocation of responsibilities within specialist care.
For a better understanding on the pathways to care, multiple factors influencing in all
the levels introduced by Goldberg have to be considered, such as barriers in help-seeking
in the public, the ways of reaching the diagnosis of depression in primary care, the
possibilities of following practice guidelines among doctors and compliance in patients,
and finally, the rules in allocating resources and responsibilities within and between the
health care providers.
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4.9.2 Help-seeking behaviour
Only a minority of primary care patients with depressive disorders have sought treatment
for depression. A major obstacle in primary care studies has appeared to be stigma
(Cooper-Patrick et al., 1997, Docherty, 1997), that is the negative stereotyping related
to persons with mental illnesses (Link et al., 2006). Furthermore, the decision to seek
help is influenced by expectations regarding the care (Cooper-Patrick et al., 1997),
attitudes towards professional help and beliefs about the helpfulness of different types
of treatment (Fortney et al., 1998). More than one third of primary care patients with
depression seem to be reluctant to accept the diagnosis (Williams et al., 1999).
4.9.3 Recognition of depressive disorders in primary care
Primary care doctors often have a difficult task, from several presenting problems and
clues, to distinguish symptoms of psychological origins (Klinkman, 1997). About half of
all depressive disorders are overlooked at a consultation (Coyne et al., 1995); at
subsequent visits, however, the rate of recognition increases modestly (Kessler et al.,
1999a).
Various patient-, doctor- and provider-related factors may influence the possibility of
depression remaining unrecognized. Patients may not realize the need for treatment (Tylee
et al., 2007) or they do not want it (Olfson, 1991a). Though the majority of patients with
depression present with physical symptoms (Simon et al., 1999b), particular complaints,
such as sleep disturbances, non-specific musculoskeletal pains, back pain, shortness of
breath, or amplified and multiple or vaguely stated complaints, have appeared to
distinguish depressed patients from non-depressed primary care patients (Gerber et al.,
1992).
Increasing the "hit rate" of recognition is an option, as the majority of individuals with
untreated depression consult their primary care doctors on other health questions (Tiemens
et al., 1996, Bebbington et al., 1997). The diagnosis of depression may, however, be
missed due to multiple doctor-related causes such as the doctors’ negative attitude
towards mental health problems, the doctors not feeling responsible for dealing with them
(Main et al., 1993, Robbins et al., 1994) or their lack of communication skills (Goldberg
et al., 1993). Primary care doctors appear, however, to respond to meaningful clinical
clues in assigning the diagnosis of depression such as distress, severe symptoms of
depression, co-morbid anxiety or history of treatment for depression (Coyne et al., 1995,
Schwenk et al., 1996, Klinkman et al., 1998, Wittchen et al., 2001). Particularly
depression with moderate or severe disability has been consistently recognized in studies
across centres (Ormel et al., 1994, Von Korff et al., 1996b). On the other hand,
depression is particularly likely to be overlooked in patients with true physical illness
(Coulehan et al., 1990b) and in those who present with somatic complaints (Gerber et al.,
1992, Kirmayer et al., 1993). The recording of the depression diagnosis in the medical
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records is less likely to happen during visits made by elderly patients and on shorter
visits (Harman et al., 2001). Overall, attempts to influence clinician behaviour through a
process of adaptation and extension of guidelines have not succeeded in changing detection
rates (Croudace et al., 2003).
According to the WHO PPGHC study, the recognition of depression was considerably better in
centres with a client-centred care model: personal doctor, no or short waiting time,
medical records kept on all patients seen and physicians responsible for aftercare of
illnesses. Even in client-centred practices the primary care doctors may, however, lack
time and facilities, when bureaucratic complexity increases their workload in poorly
organized practices (Mechanic, 2001).
4.9.4 The consequences of unrecognition
While the recognition in primary care is more probable in more severe and disabled
patients (Coyne et al., 1995), it has been suggested that the consequences of missing the
diagnosis might not have great clinical importance (Goldberg et al., 1998). Only
short-term, but not long-term, improvement in outcome has been reported in relation to
recognition and appropriate diagnosis (Goldberg et al., 1998, Simon et al., 1999a).
Overall, the poor prognosis among patients with both undetected depression (Rost et al.,
1998) and detected depression suggests that improving the "hit rate" is only a first step
toward more appropriate treatment (Goldberg et al., 1998, Simon et al., 1999a). Besides
the primary care doctor must be offered the resources to deal with the cases they discover
(Tiemens et al., 1996).
4.9.5 Screening for depressive disorders
Screening seems to improve the accuracy of identifying depression (Pignone et al., 2002).
For screening, a number of useful and accurate tools are available (Williams et al.,
2002), such as Beck’s Depression Inventory (BDI) (Beck et al., 1961) and Depression Scale
(DEPS) (Salokangas et al., 1995); even two verbally asked questions concerning lowered
mood and anhedonia seem to detect most cases of depression in primary care (Arroll et al.,
2003).
Screening alone, however, is unlikely to be a clinically or cost-effective way to improve
the mental well-being of the population (Gilbody et al., 2006), but as a part of an
integrated management system, evidence exists of improvement in patient outcome (Pignone
et al., 2002, Bijl et al., 2004). The available positive evidence led the U.S. Preventive
Services Task Force (USPSTF) to recommend that adults be screened for depression "in
clinical practices that have system in place to assure accurate diagnosis, effective
treatment, and follow-up" (Pignone et al., 2002). In England, as well as in Finland,
screening has been supported more cautiously. The National Institute for Health and
Clinical Excellence (NICE) recommends that it should be offered to people at high risk of
depression (NICE, 2004), such as patients with diabetes (Isometsä et al., 2003, Katon et
al., 2004b).
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Although the optimal interval for screening is unknown, the U.S. task force stated
"recurrent screening may be most productive in patients with past history of depression,
unexplained somatic symptoms, co-morbid psychological conditions, substance abuse, or
chronic pain" (Pignone et al., 2002). In cost-utility analysis one-time screening appears
cost-effective; Moreover, cost-effectiveness is likely to improve if treatment becomes
more effective (Valenstein et al., 2001).
4.9.6 Treatment guidelines for depressive disorders
Several sets of evidence-based practice guidelines have been published in order to improve
treatment of depression (Cohen et al., 1997, Ellis et al., 2002, Isometsä et al., 2003,
Bech, 2004, NICE, 2004, Goldberg, 2006). There exists some variation in the
recommendations; the main treatment modalities in all of them, however, consist of
pharmacotherapy, psychotherapy and electroconvulsive therapy (figure 4.).
Figure 4. Treatment guidelines for acute Major Depressive Disorder in the national Finnish 
current care guidelines for the treatment of depression (Isometsä et al., 2003).
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Treatment trials  in  primary  care  settings  have shown  that the  efficacy of antidepressants
as well as psychotherapy in the treatment of MDD transfers from specialist care to primary
care (Schulberg et al., 1998). Of them, antidepressive medication is probably the far most
offered treatment modality in primary care. There is strong evidence that antidepressants
are effective in treatment of dysthymia as well, despite the limited amount of long-term
documentation (Bech, 2004).
Increasing evidence supports the use of a specific psychotherapy in the continuation and
maintenance phases to prevent recurrences (AHCPR, 2000, Isometsä et al., 2003). Clinical
features that may suggest the use of psychotherapeutic intervention (cognitive,
behavioural, interpersonal, psychodynamic) include the presence of psychosocial stressors;
concerning intrapsychic conflict, interpersonal difficulties, or co-morbid Axis II
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disorders; especially in moderate to severe MDD, psychotherapy may be combined with
medication (AHCPR, 2000). Poor adherence to treatments may also warrant a combination of
treatment modalities (AHCPR, 2000). In a recent systemic review, Pampallona et al. (2004)
concluded that combined antidepressant therapy and psychosocial treatment is associated
with a higher improvement rate than pharmacotherapy alone (Pampallona et al., 2004).
Furthermore, guidelines suggest that treatment should aim at full recovery i.e. the
patient is symptom free and able to function well socially and at work (Bech, 2004).
A number of studies based on these guidelines have demonstrated significant improvements
in outcomes when the implementation of guidelines was accompanied by active care
management and patient education (Williams et al., 2007).
4.9.7 Treatment of depressive disorders in patients with medical illness
The factors needing special consideration in the treatment of MDD in patients with medical
illnesses are drug interactions and the potential exacerbations of medical symptoms caused
by antidepressants (Ellis et al., 2002). Considering the extent to which depression
presents in chronic medical illnesses, surprisingly, only a half of the 150 available
practice guidelines for general medical conditions have mentioned depression treatment at
all; the majority of these only addressed depression screening. Only three addressed
modifications to the general medical strategy in patients with co-morbid MDD (Kilbourne et
al., 2006). In general, Cochrane Collaboration has concluded that antidepressants improved
MDD outcome in patients with a range of physical diseases, with an overall Number Needed
to Treat (NNT) of 4.2 (Gill et al., 2007).
4.9.8 Shortcomings in treatment of depression
Despite the key role of primary care in the treatment of depression its quality remains
far from optimal there (Wittchen et al., 2001, Young et al., 2001): drug treatment
continues to be inadequate in dosage, duration, or both, and only to a small minority are
psychotherapeutic visits offered (Katon et al., 2004a). Moreover, patients are referred to
non-directive counselling, which has not shown to be effective for the treatment of
depression (Friedli et al., 1997).
Various doctor-, patient-, and provider-related factors may influence on the quality of
treatment. Patient attitudes and beliefs, according to primary care doctors, are primary
impediments to implementing guideline concordant care (Nutting et al., 2002). Patients are
reluctant to take drugs for depression (Priest et al., 1996), and only 30% to 60% of them
take their medication as prescribed (Dunn et al., 1999). The lack of availability of
adequately trained psychotherapists is another obstacle (Ebmeier et al., 2006), although
many patients prefer psychotherapy to usual care (Friedli et al., 1997).
Although following treatment guidelines is known to improve outcome, primary care doctors
frequently miss the recommendations, especially in management of suicide risk, co-morbid
56
alcohol problems and elderly patients, as well as in assessment of history and symptoms of
depression and treatment adjustment for patients who do not respond to initial treatment
(Hepner et al., 2007).
Psychiatrists and other mental health professionals are not accessible to many depressive
patients. Furthermore, health care systems often fail to organize mental health
consultation services to support the work of primary care physicians who treat their
depressive patients (Pincus, 2006).
4.9.9 Management of patients with depression in primary care
Despite the potential in primary care for a long-term and integrative perspective,
depression there remains a condition with suboptimal management. A number of educational
strategies targeted at health care professionals as well as new methods of organizing and
providing care have been proposed for its improvement (Cabana et al., 2002). Wagner has
designed chronic care models to provide the best possible functional and clinical outcomes
by optimizing the interaction between an effective practice team and the active patients
(Wagner et al., 2001). For these interactions to take place, an infrastructure needs to
support them. The effectiveness of these models is supported by results of multiple
projects, such as Prevention of Suicide in Primary Care Elderly: Collaborative Trial
(PROSPECT) (Unutzer et al., 2002) and Improving Mood-Promoting Access to Collaborative
Treatment (IMPACT) (Wells et al., 2000). In a systematic review, improvement in the
patient outcome was achieved in multifaceted strategies, where clinician education,
enhanced role of nurse case manager and a greater degree of integration between primary
and secondary care were incorporated (Gilbody et al., 2003). Examples of such strategies
have been Collaborative Care (Katon et al., 1995) and Stepped Collaborative Care
strategies (Katon et al., 1999) and IMPACT (Unutzer et al., 2002). Telephone medication
counselling delivered by a practice nurse was effective as well (Simon et al., 2000).
Beside improved quality of depression care, such disease management programs have
increased patient and provider satisfaction (Badamgarav et al., 2003, Gensichen et al.,
2005), and may successfully be implemented in a wide range of primary care settings and
geographic sites, serving diverse ethnic and socioeconomic groups with promising results
(Dietrich et al., 2004) and with only modestly increased overall costs of care
(Neumeyer-Gromen et al., 2004). Moreover, simple guideline implementation and educational
strategies have been generally ineffective, such as the large educational program in
Hampshire Depression Project, which failed to improve outcome for patients (Thompson et
al., 2000).
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4.9.10 Referral to mental health services
The majority of patients who receive specialist psychiatric care have entered the services
via primary care (Gater et al., 1991). Referral to psychiatric care in various national
practice guidelines is recommended for patients with psychotic depression and at a high
risk of suicide, and less consistently, for other patient groups with characteristics
related to poor prognosis such as illness severity, co-morbid personality disorder and
non-succesful treatment by the primary care doctor (Cohen et al., 1997, Ellis et al.,
2002, Isometsä et al., 2003, Bech, 2004, Goldberg, 2006).
When choosing the service provider some barriers are met. One is set up by the health care
system, where complex rules of funding dictates the availability of specialist services
(Docherty, 1997). Another is the patient resistance, which may appear as an obstacle in
the referring procedure. Patients’ beliefs about the helpfulness of different types of
providers and treatment influence the choice of provider (Fortney et al., 1998) and many
patients have negative attitudes towards psychiatric treatments (Demyttenaere et al.,
2000). More than half of primary care patients may be hesitant to see a mental health
specialist (Williams et al., 1999). Those who attribute their symptoms to medical illness
are especially reluctant to accept a referral (Olfson, 1991b).
4.9.11 Differences in patients with depressive disorders between primary
care and specialist care
Due to the many factors influencing on the referring process, the division of patient
populations may not be optimal between primary care and specialist mental health care.
Only few studies, however, have focused on the actual differences between depressive
disorders in primary care vs. mental health specialist care.
Of the large epidemiological surveys, ECA has compared patients with depressive disorders
receiving their treatment in the general medical setting to those receiving their
treatment in the psychiatric setting. Psychiatric setting was in ECA associated with
co-morbidity and history of inpatient care (Cooper-Patrick et al., 1994, Burns et al.,
2000).
In the Medical Outcome Study (MOS), mental health specialists, especially psychiatrists,
encountered more severely depressed patients, but patients in all sectors were sick enough
to warrant treatment (Wells et al., 1995).
Two other major studies with direct comparisons between settings have shown minimal
differences in patient characteristics. The first of these included patients with new
prescriptions (Simon et al., 2001), the latter compared patient consenting to treatment as
a part of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study
(Gaynes et al., 2005).
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Screened MDD patients in both primary care and specialist care have been investigated in
only one large clinical study, where primary care patients appeared to have less past
treatment for depression, but, surprisingly more lifetime co-morbidity (Schwenk et al.,
1996). Compared with specialists’ patients primary care patients’ functional limitations
may be different (Stewart et al., 1993) or slighter (Schwenk et al., 1996). Moreover, the
patients receiving treatment for depression exclusively in primary care have more adverse
attitudes and beliefs to care than those seen in psychiatric care (Van Voorhees et al.,
2003). Concerning sociodemographic variables, based on these studies, depressive primary
care patients seem to be older, more often female and less educated than specialists’
patients are.
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5  AIMS OF THE STUDY
In this study clinical characteristics, co-morbidity course and outcome, and pathways of
care were investigated in 137 primary care patients with DSM-IV MDD and subsyndromal
depressive disorders.
Specific aims of the study were as follows:
I   To obtain a broad view on patients’ presenting complaints, severity of depression, Axis
    I, II and III co-morbidity, and on the retrospective longitudinal course of the
    depression.
II  To examine the prevalence and risk factors for current and lifetime non-fatal suicidal
    behaviour in primary care patients with clinical depression.
III To describe the differences in terms of severity, co-morbidity, and clinical course of
    depression,  suicidal behaviour,  attitudes towards treatment and  pathways of care
    between patients with MDD in primary care vs. secondary level psychiatric outpatient
    and inpatient care.
IV  To assess the prospective course and outcome of depressive disorders and whether
    features of depression itself and co-morbidity would significantly predict them.
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6  MATERIALS AND METHODS
6.1 General Study designs
The  Vantaa  Primary  Care  Depression  Study  (PC-VDS)  is a naturalistic  and  prospective
cohort study concerning major and subsyndromal depressive disorders in primary health
care. It forms a collaborative depression research project between the Department of
Mental Health and Alcohol Research of the National Public Health Institute, Helsinki,
Finland and the Primary Health Care Organization of the City of Vantaa, Finland. Vantaa is
a city of 179856 inhabitants (in 2002). The catchment area in Vantaa comprises two
districts with about 63400 inhabitants, served by 30 general practitioners with
population-based responsibility. The western sampling area represents a more affluent, and
the eastern a more disadvantaged part of the city; together, these two areas are
sociodemographically representative of the whole of Vantaa (2002).
Because of the different foci of the studies, the publications had different patient
samples as presented in Table 4.
Table 4. Composition of study populations in the original publications.
  Study               Vantaa Primary Care Depression Study      Vantaa Depression Study     Total
  Number                                                                                    number of
                        (major depressive disorders and           (major depressive           patients
                        subsyndromal depressive disorders)        disorders)
  Study I               Patients evaluated at baseline,                                       137
                        N=137
  Study II              Patients evaluated at baseline,                                       137
                        N=137
  Study III             Patients evaluated at baseline,           Patients evaluated at       343
                        N=74                                      baseline, N=269
                        (46 patients with subsyndromal
                        depressive disorders and patients
                        over 59 years excluded)
  Study IV              18-month follow-up, N=134                                             134
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6.2 Screening
Primary Care Evaluation of Mental Disorders (PRIME-MD) (a 27-item self-report screening
questionnaire designed to facilitate the diagnosis of common mental disorders in primary
care) (Spitzer et al., 1994) was given to consecutive patients, aged 20-69, in general
practitioners’ waiting rooms on randomly selected days between 2 January and 31 December
2002, stratified in terms of weekday, day of month and time of year in the first stage of
the patient sampling. It was not offered to subjects not understanding Finnish (N=50), in
medical emergency (N=14) or to handicapped subjects unable to communicate (N=4).
Altogether 1119 patients received PRIME-MD. Screening was considered positive if the
patients answered "yes" to either question concerning depressed mood or anhedonia in
PRIME-MD ("during the past month, have you often been bothered by: (1) feeling down or
depressed or hopeless, or (2) little interest or pleasure in doing things"). The 402
screening positive patients were fully informed about the study and were asked for their
permission to accept a phone call within five days from the research psychiatrist
(M.Vuorilehto).
A total of 375 consenting patients, after PRIME-MD screening, were interviewed by phone by
the researcher (MV) for 20-30 minutes. Previous psychiatric diagnosis and current
treatment were asked; symptoms of depression were assessed with the current depressive
episode module of Structured Clinical Interview for DSM-III-R Axis I Disorders Patient
Edition (SCID-I/P) (First et al., 2001). Patients with depressive mood or anhedonia plus
distress or impairment due to depression for at least two weeks during the previous month
were included. Exclusion criteria were current treatment by a psychiatrist (N=32), bipolar
or organic mood disorder, or psychosis other than depressive (N=14), and alcohol use
problems severe enough to prevent the diagnostic interview (N=10).
The detailed methodology of the Vantaa Depression Study (VDS) has been reported elsewhere
(Melartin et al., 2002). In short, the PC-VDS was planned to be comparable with the VDS.
In VDS, in secondary psychiatric out- and inpatient care, patients aged 20-59 years were
screened for an incident major depressive episode if they were seeking help by
self-referral, referred to treatment, or were already in treatment but had an acute
deteriorating clinical state (Melartin et al., 2002). The screening instruments in the VDS
comprised the five screening questions for MDD from the Schedules for Clinical Assessment
of Neuropsychiatry (SCAN) (Wing et al., 1990) and the Scale for Suicidal Ideation (SSI)
(Beck et al., 1979). Exclusion criteria in the VDS included diagnosis of bipolar mood
disorder or schizophrenia. Of the 806 patients who were screened, 703 were positive; of
them 161 refused further interview (22.9% of the screened).
62
Figure 5. Flow chart of the screening process in Vantaa Primary Care
Depression Study.
        PRIME-MD screens                       Refused        Negative
        N=1119                                 N=8            N=709
        Positive (36%)                         Refused telephone
        N=402                                  interview
                                               N=27
        Completed telephone                    Ineligible
        interview                              N=190
        N=375
        Potentially eligible                   Refused face-to-face
        N=185                                  interview
                                               N=10
        Completed                              Failed to fulfil the
        face-to-face SCID-I                    research criteria  N=34
        interview
        N=175                                  Excluded for other
                                               reasons N=1
        Eligible                               Refused to participate
        N=140                                  N=3
        Included in PC-VDS
        N=137
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6.3 Baseline evaluations
6.3.1 Diagnostic measures
The 175 potentially eligible patients, after giving their written informed consent, were
interviewed face-to-face using DSM-IV SCID-I/P with psychotic screen to ascertain whether
or not the mood episode during the previous month satisfied the inclusion criteria for the
cohort: 1. current MDD, 2. Dysthymia, 3. subsydromal depression (subMDD) with two to four
current depression symptoms (at least one core symptom) and fulfilling the criteria of
lifetime MDD, or 4. Minor Depression (MinD) with two to four depression symptoms (at least
one core symptom) without any history of MDD, thus satisfying DSM-IV criteria. Current
distress or functional impairment was required for inclusion in all these groups.
Dysthymia was recoded as a co-morbid diagnosis. Four (3%) patients who fulfilled the
diagnostic criteria of Dysthymia and had a lifetime history of MDD were included in the
subMDD group; one patient without a history of MDD was included in the MinD group.
All available medical records, including the results of a standardized set of laboratory
tests, were used to exclude substance-induced depression or depression due to medical
conditions. Patients currently abusing alcohol or other substances were interviewed after
two to three weeks of abstinence, in order to exclude substance-induced mood disorders. In
order to gain a full picture of current (previous month) and lifetime Axis I disorders
each patient’s inclusion in the study cohort was followed by an interview with use of the
entire SCID-I/P with psychotic screen. SCID-II (First et al., 1997) was used to assess
diagnoses on Axis II. Axis III diagnoses were evaluated via a self-report questionnaire
and information from medical records and the interview. Chronic medical illness diagnosed
by a doctor, minimum duration three months and with functional impairment and/or constant
suffering, was regarded as current somatic co-morbidity.
The diagnostic joint reliability was analysed by using 20 randomly selected videotaped
interviews concerning diagnostics of mood disorders, modified so as not to reveal to the
second diagnostician (T.Melartin) the first interviewer’s (MV) decisions. The observed
agreement rate for current MDD and current subsyndromal diagnoses was 100%, with kappa
coefficient=1.0, for both.
In the VDS, current episode of MDD and Axis I co-morbid disorders were diagnosed in a
face-to-face interview using the World Health Organization Schedules for Clinical
Assessment in Neuropsychiatry, version 2.0 (SCAN) (Wing et al., 1990). The SCID-II for
DSM-III-R (Spitzer, 1987) was used to assess the Axis II disorders. Due to differences
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between the diagnostic tools only current alcohol dependence was reported among the
substance use disorders in the comparison between primary care and psychiatric care. The
final study group consisted of 269 psychiatric patients all with a current episode of
MDD. Inter-rater agreement in diagnostic interviews was excellent (kappa
coefficient=0.86)(Melartin et al., 2002).
6.3.2 Observer and self-report scales
Observer report scales included the 17-item Hamilton Rating Scale for Depression (HAMD)
(Hamilton, 1960) , the Scale for Suicidal Ideation (SSI) (Beck et al., 1979) and the
Social and Occupational Functioning Assessment Scale for DSM-IV (SOFAS) (Goldman et al.,
1992). Self-report scales included the 21-item Beck Depression Inventory (BDI) (Beck et
al., 1961), Beck’s Anxiety Inventory (BAI) (Beck et al., 1988), the Beck Hopelessness
Scale (HS) (Beck et al., 1974) and the Perceived Social Support Scale − Revised (PSSS-R)
(Blumenthal et al., 1987).
6.3.3 Other characteristics
A retrospective lifetime course for depression (age of onset, duration and recurrences
before entry, as well as chronicity of MDD according to DSM-IV criteria) was reconstructed
from the interview and medical and psychiatric records. Age at illness onset was defined
as onset of the first mood episode that fulfilled DSM-IV criteria for a MDE.
Patients were asked the subjective reason for their index visit to the primary care
doctor. The reasons were classified as: 1. somatic, if the patient reported it as either
preventive or only somatic, 2. psychological, if it was only psychological or
psychological accompanied by somatic. The specific presenting complaints were asked in a
questionnaire, which also included a standard battery of sociodemographic variables (age,
gender, marital status, education and employment status).
Suicidal behaviour was investigated in three time frames: a) current suicidal ideation, b)
ideation and attempts within the ongoing depressive episode, and c) lifetime ideation and
attempts. Here, suicidal ideation refers to patients who scored ≥ 6 on the SSI. Suicidal
behaviour during the ongoing depressive episode and lifetime suicidal behaviour, was
reconstructed from medical and psychiatric records and by questioning the patient about
seriously considered or attempted suicides. By definition, a suicide attempt had to
involve at least some degree of intent to die; self-harm with no suicidal intention was
not classified as a suicide attempt. The number of visits with the primary care doctor and
doctors’ notes about suicidal behaviour were calculated from medical records of the
preceding year. Consultation with the doctor about depressive symptoms during the current
episode was asked about in the interview. Lifetime treatment history for depression and
current use of medication was reconstructed from the interview and medical and psychiatric
records.
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Attitudes towards antidepressant and psychotherapeutic treatments were assessed separately
in the interview with the following response alternatives: 1) actively wants treatment, 2)
passively accepts treatment, 3) has reservations about treatment, 4) has a clearly
negative attitude towards treatment, and 5) could not answer. In the analysis, items 1 and
2 were considered positive attitudes and items 3 and 4 were considered negative (Melartin
et al., 2005).
The point of first contact with health care for depressive symptoms was classified as
either a) general medical or b) mental health contact. Contacts involving either the
patient’s active seeking of help or recognition of depression by a healthcare professional
were included as first contacts. General medical contact was defined as seeing a
non-psychiatric physician or other health professional in any primary care or medical
setting (in Finland addiction treatment settings are usually regarded as a part of primary
care; 1 primary care patient and 5 psychiatric patients had first contacted there in this
study). Mental health contact was defined as either seeing a psychiatrist or psychologist
(irrespective of setting) or any other professional (e.g. nurse or social worker) in
psychiatric care.
Patients who refused further study participation at any stage (15%) did not differ
significantly in age or gender from those who complied.
6.4 Follow-up
6.4.1 Study population in the follow-up
During the 18-month follow-up time the diagnosis of four patients (3%) switched to bipolar
disorder; they were censored in the survival analysis at the time-point in the life-chart
where the switch occurred. The final follow-up group in the survival analysis consisted of
134 patients, all with information from at least one of the three follow-up points: 89
patients with baseline MDD and 45 with baseline subsyndromal depressive disorder, of the
latter, 32 subsyndromal depression with a history of MDD (subMDD) and 13 with baseline
MinD.
6.4.2 Study drop outs
Of 137 subjects at baseline, only three subjects (2%) dropped out from all follow-ups. In
addition, two more subjects (2%) were missing at 6 months and altogether 10 subjects (7%)
at 18 months. Besides them, the four patients with bipolar disorders were not present at
the 18-month interview.
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6.4.3 Integration of information into a life-chart
Patients were prospectively followed up with a life-chart − similar to the VDS methodology
(Melartin et al., 2004) − to determine the duration of the index episode and the timing of
possible relapses and recurrences. Information was gathered at three time-points: the BDI
was rated at 3, 6 and 18 months, self-report scales were included at 3, 6 and 18 months,
and the current diagnosis of depression was investigated by telephone at 6 months and
face-to-face at 18 months (median 18.7) by SCID-I interviews. In addition, observer scales
were used at the 18-month assessment. To improve the accuracy of the assessment of change
points in the psychopathologic states, probes relating to important lifeevents were used.
All available data was used, including patient records during the follow-up, which was
then integrated into the graphic life-chart. For that purpose, notes concerning the
patients’ psychopathologic state in the primary care medical records were thoroughly
examined; at the same time the number of visits to the primary care doctor were counted.
Those contacts with the doctor were counted separately that included according to the
notes, discussion about the patients’ depressive disorder or its symptoms.
6.4.4 Definitions for time periods of life-chart
The life-chart was based on DSM-IV criteria and definitions. The time after the baseline
was divided into periods spent in three kinds of symptom states: (1) state of MDE (5 or
more of the 9 MDE criteria symptoms), (2) state of partial remission (1-4 symptoms) or (3)
state of full remission (no symptoms).
6.4.5 Principal outcome measures
Besides the cross-sectional diagnostic status at the end of the follow-up period, the
principal outcomes for baseline MDD were 1) duration of index MDE with full criteria, 2)
time to full remission after index MDE, 3) relapses and recurrences. For the baseline
subsyndromal depressive disorders the principal outcome measures were 1) time to the
turnover of the subsyndromal symptom state to a MDE, or to non-symptomatic state (Table
5.).
Definitions of remission and relapse followed DSM-IV criteria, and recurrence followed the
DSM-IV definition for "296.3x MDD, Recurrent". State of remission (further specified as
full or partial) required at least two consecutive months in which MDE criteria were not
met. Relapse referred to the return of symptoms fulfilling MDE criteria after a period of
more than two weeks but less than two months with symptoms below the MDE threshold.
Recurrence referred to the return of MDE after at least two consecutive months of partial
or full remission.
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Table 5. Definitions of the time after the baseline among patients with depressive
disorders in Vantaa Primary Care Depression Study. 
Patients with major depressive disorder at baseline
  1) Duration of major depressive episode (MDE)       The uninterrupted duration of the episode in
          in full criteria (5 or more symptoms)       the state of MDE
  2) Time to full remission                           Time to the first onset of state of full
                                                      remission (no symptoms) lasting at least two
                                                      consecutive months
        Patients with subsyndromal depression at baseline
  1) Time to non-symptomatic state                    Time to the first onset of state of full
                                                      remission or with no symptoms lasting at
                                                      least two consecutive months
  2) Time to MDE                                      Time to the first onset of state of MDE with
                                                      full criteria (5 or more symptoms)
6.5 Statistical methods
Between-group comparisons involving categorical data were computed using the chi-square
statistic with Yates’ correction for continuity, and Fishers’ exact test when appropriate
(expected cell count less than 5 in a 2x2 table), while between-group comparisons using
continuous data were computed with either Student’s t-test, Kruskall-Wallis or
Mann-Whitney test, depending on the type of distribution. Multivariate methods, including
binary and multinomial logistic regression models, were used to adjust for confounding
factors. In the analyses on outcome Kaplan-Meier survival curves were used to estimate
the probability of remaining ill during the 18-month follow-up. Cox proportional hazards
models were used in the multivariate analyses for predicting time to a change in the
symptom state. In hypothesis testing a p-value <.05 was considered significant. 95%
confidence intervals (95% CI) were used when appropriate. Statistical Package for the
Social Sciences for Windows (SPSS) software, version 11.0, 12.0, and 14.0, was used.
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7  RESULTS
7.1 Sociodemographic features of the study cohort
The cohort of 137 patients consisted of 76% women, mean age 44.4 years, and 24% men, mean
age 48.1 years with no significant sociodemographic gender differences. Of patients 35%
were living alone, and 20% were unemployed. Overall, 62% of the patients were recruited
from western Vantaa, reflecting the proportions screened in each area and the general
population distribution (Study I).
7.2 Current severity of depression and retrospective longitudinal
course
Two thirds (66%) of the cohort suffered from current MDD, which was distributed evenly
between mild (39/91) and moderate MDD (45/91); a few had severe MDD (7/91). Of current
MDD 21% was persistent.
One third (34%) of the cohort suffered from subsyndromal depressive disorder. Of them,
only one third (14/46) were true MinD cases. Two thirds (32/46) were subsyndromal patients
with lifetime MDD (subMDD), of whom 59% were currently in partial remission, and 41% had
already been in full remission prior to current symptoms. The MinD and subMDD patients had
significantly less depressive and anxiety symptoms than the MDD patients (HAMD 12.3
[S.D.5.9] vs. 11.9 [4.1] vs. 18.2 [4.7] p<0.001, BAI 8.3[S.D.2.8] vs. 9.1 [5.6] vs. 20.9
[13.2]). Of the MDD and the subMDD patients two thirds (77/123) had had at least one and
one third (46/123) three or more preceding MDEs (Study I).
7.3 Contacts with health care
7.3.1 Reason for index visit and specific presenting complaints
One third of patients (47/137) reported a psychological reason for the index visit such as
"burn out" or "anxiety", which was independently predicted by higher HAMD score (OR 1.15
[95% Cl 1.06-1.24] p=0.001) and younger age (OR 0.97 [0.94-0.99] p=0.018). Gender,
psychiatric or chronic somatic co-morbidity, or phase or duration of depression had no
influence on the reported reasons.
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Of specific presenting complaints the largest group was various pain symptoms, in 26 % of
the patients, which associated with co-morbid anxiety disorder after adjusting for age,
gender and medical co-morbidity (OR 3.26 [1.27-8.40] p=0.014). Of specific presenting
complaints "depression" or "burnout" (21/137) was independently predicted by higher HAMD
(OR 1.16 [1.05-1.29] p=0.004) and younger age (OR 0.96 [0.92-0.99] p=0.04) (Study I).
7.3.2 Retrospective contacts with health care among patients with MDD
Of the patients with MDD, 37% had not contacted health care for depressive symptoms during
this episode; their depression was markedly milder and fewer of them had positive
attitudes towards medication (33% vs. 72%, p=0.001). Half (50%) of the primary care
patients with MDD had initially contacted general medical services. The remaining 13%,
with more suicidal behaviour during the ongoing episode (50% vs. 16%, p=0.039), had
directly approached mental health services.
Of all patients with MDD, 22% had contacted mental health services at some point during
the ongoing episode. The majority of these patients had a chronic course (63%) and severe
symptoms of depression (HAMD 21.3 [SD 4.56]), with co-morbid personality disorder (75%);
during the MDE half of them had considered suicide (50%) and a quarter had attempted it
(25%) (Study III).
7.3.3 Contacts with primary care doctor during the follow-up
During the 18-month follow-up, one or more visits to a primary care doctor could be
verified from the patient records in nearly all patients (117/123). For patients with
baseline MDD the median number of visits was 7 (percentiles 25-75: 4-11), for patients
with subsyndromal depressive disorders it was 5 (2-8).
According to notes made by doctors, 81% (64/79) of the patients with MDD had discussed
their depression with their primary care doctor; median number of contacts where
depression was an issue was 2 (percentiles 25-75: 1-6). Of patients with baseline
subsyndromal depressive disorders 59% (26/44) had discussed depression during a median one
(0-3) contact (unpublished data).
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7.4 Co-morbidity
7.4.1 Current Axis I, II and III co-morbidity
Nearly all patients had current co-morbidity (Figure 6.). In univariate analysis highest
rates in overall psychiatric co-morbidity, as well as in anxiety and personality disorders
were found in the MDD group (Tables 6. and 7.)
Figure 6. The overlapping co-morbidity in depressive disorders among 
primary care patients. 
Co-morbidity of Axis II
disorder 52%
Co-morbidity of chronic
medical illness 47%
Co-morbidity of Axis I
disorder 59%
Depression without
any co-morbidity 12%
6%
20%
9%
17% 14%
15%
7%
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Table 6. Any co-morbidity, medical co-morbidity or Axis I co-morbidity in
primary care depressive disorders.
                                 Major             Subsyndromal      Minor             P-value
                                 depressive        depressive        depression
                                 disorder          disorder          (N=14)
                                 (N=91)            (N=32)
  Any co-morbidity                  95 %              81 %              57 %              <0.001
     Psychiatric co-morbidity       82 %              66 %              50 %               0.028
     Chronic medical co-morbidity    50 %              44 %              27 %              NS
  Co-morbid Axis I diagnosis
     Dysthymia                      12 %               9 %               7 %              NS
     Anxiety disorder               50 %              25 %              36 %               0.036
     Eating disorder                 2 %               3 %              -                 NS
     Somatoform disorder            14 %              12 %              -                 NS
     Substance use disorder         16 %               3 %               7 %              NS
Table 7. Axis II co-morbidity in primary care depressive disorders.
                                 Major            Subsyndromal       Minor             P-value
                                 depressive       depression with    depression
                                 disorder         a history of       (N=14)
                                    (N=91)           major depression
                                                     (N=32)
  Co-morbid Axis II diagnosis       58 %             47 %               21 %              0.030
    Cluster A                        7 %              3 %                -                NS
      Paranoid                       5 %              3 %                -                NS
      Schizoid                       -                -                  -
      Schizotypal                    1 %              -                  -                NS
    Cluster B                       35 %             19 %                7 %              0.037
      Antisocial                     4 %              -                  -                NS
      Histrionic                     2 %              -                  -                NS
      Borderline                    32 %             16 %                7 %              0.048
      Narcissistic                   7 %              3 %                -                NS
    Cluster C                       35 %             31 %               14 %              NS
      Obsessive-compulsive          12 %             12 %                7 %              NS
      Dependent                      3 %              -                  -                NS
      Avoidant                      20 %             22 %                7 %              NS
      Passive-aggressive             7 %              3 %                -                NS
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After adjusting for HAMD, the MDD group did not differ from subMDD, whereas the MinD
group tended to have a lower prevalence of personality disorders (OR 0.72 [95% CI
0.06-1.02] p=0.054). Psychiatric co-morbidity was associated with higher symptom severity
of depressive disorder. This was true for overall psychiatric co-morbidity (HAMD mean 16.8
vs. 14.2, p=0.023), as well as among Axis I co-morbidities for both anxiety disorders
(HAMD mean 17.4 vs.15.1, p=0.009) and substance use disorders (HAMD mean 19.1 vs. 15.7,
p=0.011). Moreover, it was also true for Axis II disorders (HAMD mean 17.0 vs. 15.2,
p=0.048). The total number of all co-morbid psychiatric diagnoses correlated with HAMD
scores (Spearman r=0.31, p<0.001) (Study I).
7.5 Suicidal behaviour
7.5.1 Current suicidal ideation in SSI
At the time of the interview, 18% of the subjects scored high on the SSI (≥6). Almost all
with high SSI were MDD patients (23/137); of them 15 had attempted suicide. Prior
psychiatric treatment was the strongest predictor of high SSI after adjustment for gender
(OR=19.60 [95% CI 4.05-94.81] p=<0.001), other predictors were younger age (OR=0.92
[0.87-0.97] p=0.001), hopelessness (HS; OR=1.16 [1.03-1.311] p=0.01) and more severe
depression (HAMD; OR=1.14 [1.00-1.31] p=0.046). A history of suicide attempts instead of a
history of psychiatric care was associated with a high SSI as well when adjusted to the
model (OR=9.08 [2.54-32.39] p=0.001) (Study II).
7.5.2 Suicidal behaviour within the ongoing depressive episode
Of all the patients, 24% had experienced suicidal ideation and 4% had attempted suicide
during the ongoing episode. Both ideation and attempts clustered with abundant
co-morbidity. The suicidal behaviour was independently associated with psychiatric
treatment during earlier episodes; other predictors were younger age, severity of
depression symptoms and co-morbid personality disorders as shown in table 8. (Study II).
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Table 8. Predictors of suicidal behaviour during the ongoing depressive episode.
                               No suicidal   Suicidal ideation (N=27)       Suicide attempt (N=6)
                               behaviour
                               (N=104)
                                  Odds ratio    Odds    95%            P-      Odds    95%            P-
                                                ratio   confidence     value   ratio   confidence     value
                                                        interval                       interval
  Age                               1.0         0.95    0.91 to 0.99   0.010   1.01    0.93 to 1.09   NS
  Gender                            1.0         0.98    0.31 to 3.08   NS      *
  Hamilton Depression Rating
  Scale score without suicidal
  item                              1.0         1.17    1.04 to 1.32   0.008   1.25    1.04 to 1.51   0.020
  Personality disorder              1.0         4.12    1.32 to 12.99   0.015   2.23    0.07 to 3.07   NS
  Lifetime psychiatric care         1.0         3.85    1.28 to 11.63   0.012   4.88    0.47 to 50.00   NS
* the group consists of only women
7.5.3 Lifetime suicidal behaviour
Within  their  lifetimes, 37%  of  the  patients  had  had suicidal  ideation  and  17%  suicide
attempts. Lifetime suicidal behaviour was associated with a current MDD diagnosis and
severe symptoms of depression, anxiety and hopelessness, personality disorders and
psychiatric treatment history. Treatment in psychiatric care some time over lifetime had
very strong association with suicide attempts (OR 18.61 [95% CI 3.85-100.00 ] p<0.001)
(Study II).
7.5.4 Notes of suicidal ideation and treatment of depression
Only a quarter of current suicidal ideation had been noted (24%) by the doctors in the
medical records. The doctors had, however, recognized the depression in all patients with
suicide attempts, and in 70% of patients with ideation, and offered antidepressive
medication to 83% and 70% respectively. Of the attempters, 83% had received specialized
psychiatric care and 67% had been in psychiatric hospital during the current MDE (Study
II).
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7.6 Differences between patients with MDD in primary care and
specialist care
7.6.1 Sociodemographic differences
The primary care patients, the psychiatric outpatients and the inpatients were similar in
age, gender, marital status, educational background, employment status and perceived
social support as measured with the PSSS-R. The primary care patients were, however, more
often on disability pension for medical reasons than the out- and inpatients (7% vs. 1%
vs. 2%, p=0.016) (Study III).
7.6.2 Differences in clinical characteristics
Based on HAMD scores the primary care patients and the psychiatric outpatients were
equally depressed (17.9 vs. 18.1), but BDI scores were lower in primary care (23.5 vs.
27.5, p=0.004). The inpatients had significantly more severe symptoms of depression than
the other two groups (HAMD 24.9, p<0.001) and a lower level of functioning in SOFAS
(primary care patients 54.9 vs. outpatients 53.9 vs. inpatients 41.7, p<0.001), and
psychotic subtype among them was markedly higher (1% vs. 5% vs. 26%, p<0.001) (Study III).
7.6.3 Differences in Axis I and Axis II co-morbidity
Compared with primary care patients, psychiatric outpatients and inpatients had more
agoraphobia (3% vs. 11% vs. 13 %, p 0.049), the inpatients more alcohol dependence
(primary care patients 4% vs. outpatients 11% vs. inpatients 30%, p<0.001). On the other
hand, somatization disorders were present only in primary care.
Concerning Axis II co-morbidity, of all three patient groups, in primary care the
prevalence of cluster B personality disorders (antisocial, histrionic, borderline,
narcissistic) was highest (38% vs. 12% vs. 26%, p <0.001) and Cluster A (paranoid,
schizoid, and schizotypal) lowest (5% vs. 18% vs. 26%, p 0.007) (Study III).
7.6.4 Differences in suicidal behaviour
In the comparison of primary care patients, outpatients and inpatients suicidal behaviour
(both current, during the MDE, and over the lifetime) was most frequent among psychiatric
inpatients (ideation 30% vs. 44% vs. 72%, p <0.001) (attempts 18% vs. 28% vs. 63%,
p <0.001) (Study III).
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7.6.5 Differences in the clinical history
In all three settings, the age at MDD onset was similar, around thirty years. In two
thirds of patients in all settings, MDD was recurrent. During the preceding MDEs markedly
fewer primary care patients and outpatients had been hospitalized than the current
inpatients (14% vs. 6% vs. 26%, p<0.001). Other aspects in the treatment history of
earlier episodes were quite similar: one-half had received treatment from any doctor,
one-third had received antidepressive medication and more than one-third had received
mental specialty treatment.
The duration of the current episode prior to the study interview was significantly longer
in primary care (median 6.1 months [25;75 percentiles 1.5;19.0] vs. 3.5 [2.0; 6.0] vs. 2.5
[1.0;5.0], p=0.002). A chronic course of MDD was almost exclusively found in primary care
(22% vs. 2% vs. 0%) (Study III).
7.6.6 Characteristics associated with treatment in psychiatric care
In a logistic regression model, where primary care served as reference category, symptom
severity measured with HAMD was a strong predictor of inpatient (OR 1.26 [95% Cl
1.14-1.38] p<0.001) but not of outpatient status. However, when BDI was substituted for
HAMD in the model, it proved to be a predictor of outpatient care (OR 1.07 [1.02-1.13]
p=0.007) but no longer for inpatient care. Suicide attempts (OR 2.62 [1.11-6.16] p=0.028),
alcohol dependence (OR 8.36 [1.56-44.28] p=0.013), and cluster A personality disorder
associated with treatment in psychiatric care (OR 5.88 [1.76-19.70] p=0.004); cluster B
personality disorder by contrast was very strongly associated with primary care (OR 0.08
[0.03-0.20] p=<0.001). Phobic anxiety disorders or patients’ attitudes towards treatment
did not have independent predictive value (Study III).
7.7 Prospective course and outcome of depressive disorders
7.7.1 Course and outcome of MDE
7.7.1.1. Outcome of index MDE
Of the 79 patients with baseline MDD who were followed up for the entire 18-month period,
slightly more than one-third (38%) achieved full remission of the index episode. Another
third (37%) achieved partial remission (1-4 residual depressive symptoms), and a quarter
(25%) remained with full MDE criteria (Study IV).
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7.7.1.2. Duration of index MDE with full criteria
The median duration of MDE with full criteria was 6.00 months (95% CI 4.00-8.00) after
entry. In a Cox regression model, longer duration of MDE was predicted by higher severity
of depression in baseline HAMD (Table 9.) as well as by baseline co-morbid substance use
disorder (Table 9.). Other baseline characteristics, such as perceived social support or
ongoing antidepressive medication did not have significant predictive value after
adjusting for the severity of depression and therefore they were withdrawn from the final
model. (Study IV).
7.7.1.3. Time to full remission after index MDE
In a Cox regression model, only older age and more severe symptoms of depression at
baseline predicted longer time to full remission (Table 9.) (Study IV).
7.7.1.4. Relapses and recurrences
Of the patients with baseline MDD, 75% achieved a symptom state below full MDE criteria.
Of these patients in one-third (32%), symptoms fulfilling MDE criteria, however, returned:
8% (5/59) relapsed immediately, 27% had a recurrence. In a Cox regression model, longer
time to first relapse or recurrence was predicted by milder depressive symptoms and by not
having a cluster C personality disorder (obsessive-compulsive, dependent, avoidant,
passive-aggressive) at baseline (Table 9.) (Study IV).
Table 9. Clinical predictors for the course and outcome in 18-months 
of major depressive disorders in primary care patients according to
Cox proportional hazard model.
                                                      Hazard Ratio                P-value
                                                    (95% Confidence Interval)
  Duration of the index MDE with full criteria
     Age, years                                       1.01 (0.99-1.03)            NS
     Gender, male                                     1.43 (0.81-2.50)            NS
     Hamilton Depression Rating Scale score           1.11 (1.05-1.19)            0.001
     Co-morbid substance use disorder                 3.05 (1.31-7.12)            0.010
  Time from study inclusion to full remission
     Age, years                                       1.05 (1.02-1.08)            <0.001
     Gender, male                                     1.59 (0.58-3.70)            NS
     Beck Depression Inventory score                  1.05 (1.01-1.10)            0.015
  Time from remission to first relapse or recurrence
     Age, years                                       0.98 (0.94-1.02)            NS
     Gender, male                                     0.64 (0.20-2.00)            NS
     Beck Depression Inventory score                  0.93 (0.88-0.99)            0.022
     Personality disorder cluster C                   0.37 (0.15-0.91)            0.030
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7.7.2 Prospective course and outcome of subsyndromal depressive disorders 
7.7.2.1. Outcome of the index subsyndromal symptom state
During the 18-month follow-up the baseline subsyndromal symptom state improved to a
non-symptomatic state in about half of the patients (55%). The subsyndromal state remained
persistent in one-fifth (20%), and proceeded to MDE in one-quarter of patients (25%)
(Study IV).
7.7.2.2. Time to change from subsyndromal symptom state
The median time from entry to a non-symptomatic state was 6.53 months (95% Cl 3.63-9.43).
In a Cox regression model, slower improvement was predicted by chronic medical illness (HR
2.79 [95% CI 1.10-7.05] p=0.031). Slower progress to an emerging or recurrent MDE was
predicted by baseline diagnosis of MinD (never having suffered from MDD) (HR 15.08
[1.50-151.86] p=0.21) (Study IV).
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8  DISCUSSION
8.1 Main findings
The retrospective investigation revealed current MDD in most (66%), and lifetime MDD in
nearly all (90%) clinically depressive primary care patients. Two thirds of the
"subsyndromal" cases had a history of MDE, although they were currently either in partial
remission or a prodromal phase. Recurrences and chronicity were common. The picture of
depression was complicated by anxiety (43%) and somatic co-morbidities (47%), and highly
prevalent personality disorders (52%). Psychological reasons for the index visit seemed to
suggest more severe depression.
Within their lifetimes, one-third (37%) of primary care patients with depressive disorders
had seriously considered suicide, and one sixth (17%) had attempted it. Suicidal behaviour
clustered almost exclusively in those with moderate to severe major depressive disorder,
psychiatric co-morbidity with personality disorders, and a history of psychiatric care.
The majority of patients with suicidal behaviour were receiving treatment for their
depression, but suicidal ideation had mostly remained unrecognised.
In the comparison of patients with MDD in primary care with those in secondary level
psychiatric care, most suicidal or psychotic patients were receiving treatment in
psychiatric care, and those with the most severe symptoms and functional limitations were
hospitalized. In other clinical aspects, patients with MDD in primary care were very
similar to psychiatric outpatients. Mental health contacts earlier in the current MDE were
also common among primary care patients with complicated depression.
The prospective investigation with a life-chart methodology verified the chronic and
recurrent nature of depression in primary care. Of patients with MDD one-quarter achieved
and maintained full remission in 18 months, while another quarter failed to remit at all.
The remaining patients suffered either from residual symptoms or from recurrences.
Severity of depression was the most robust predictor of recovery, but also presence of
co-morbid substance use disorders, chronic medical illness and cluster C personality
disorders also contributed to adverse outcome.
79
8.2 Methods
This is a unique clinical study in assessing the overall clinical picture including co-
morbidity of Axis-I, II and III disorders in a cohort of depressive disorders representing
the total case load of primary care depression − both recognized and unrecognized. With
use of a life-chart method, both retrospective and prospective course could be followed in
detail. The investigation on non-fatal suicidal behaviour in primary care patients with
depressive disorders was comprehensive. The clinical picture of patients with MDD in
primary care was compared with the comparative characteristics in secondary psychiatric
care, including for the first time comparison of Axis II co-morbidity.
8.2.1 Representativeness
The cohort was sociodemographically representative of the city of Vantaa. It probably
represents Finnish urban and suburban primary health care patient populations well, as the
cohort was carefully screened with rare refusals. The generalizeability, however, of our
findings to rural or foreign patient populations remains unknown. The study cohort also
reflects the true caseload of primary care doctors, as all co-morbid cases and previously
undiagnosed patients were included. However, about one third of employed persons use
occupational health care services in Finland (Notkola et al., 1992), which may have
somewhat enriched unemployed and retired patients in the cohort. In addition, an unknown
number of patients exclusively visiting ambulatory services were not included for
feasibility reasons; by clinical experience, their psychological problems might be worse.
For the comparison of primary care and secondary psychiatric care patients a large pooled
sample of MDD patients (N=343) was obtained, which effectively represents primary care and
psychiatric patients in a health district that provides free-of-charge secondary care
psychiatric services in community mental health centres. As health care systems, however,
can differ widely even within a single country and at the time of study sampling
self-referral to secondary care was allowed, the generalizability of our findings are
likely to be most relevant to settings in which patients’ own choices are important
determinants of the eventual treatment provider. Dropouts are unlikely to have biased our
outcome findings, as 90% of the cases could be assessed face-to-face at least once after
baseline, and for 98% some or all ratings were available.
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8.2.2 Screening
Using a screen at intake aimed at providing an accurate picture of the clinical caseload
of depressive disorders, both recognized and unrecognized, met by primary care doctors in
everyday work. PRIME-MD is known to be a highly sensitive but quite unspecific screening
instrument (Brody et al., 1998), and as such revealed one-third of visitors as
screeningpositive. The other available questionnaires have not appeared superior to
PRIME-MD (Williams et al., 2002). In telephone interviews, we ensured that all clinically
significant depressive syndromes were recruited for the face-to-face SCID-interview.
The probability that a depressive patient will appear in a screened prevalence-based
cohort is proportional both to the incidence of onsets and to the duration of the
depression; therefore, compared with incidence-based studies, cases of long duration are
enriched in this cohort (Cohen et al., 1984). Moreover, the patients were not recruited at
similar points in the course of their depression, the duration of the episodes in
follow-up are not comparable with results of incidence-based studies.
Concerning the comparison between primary care and specialist care the screening procedure
of PC-VDS and VDS differed unavoidably. The VDS included patients at the beginning of more
intensive treatment, and thus probably in their worst phase of depression. On the other
hand, MDD in psychiatric care might already have been somewhat alleviated due to treatment
effects. The PC-VDS focused on the cross-sectional load of MDD, thus also comprising
cases with a deteriorating or already remitting phase of illness as well as undetected
MDDs.
8.2.3 Diagnosis
The strengths of this study include thorough DSM-IV diagnostic investigation with the use
of SCID-I/P and -II, and excellent reliability for depressive disorders. The reliability
of depressive disorders in follow-up, and co-morbid psychiatric and somatic diagnoses at
baseline remains unknown. Personality disorders were diagnosed during depressive
syndromes, a fact that may (Stuart et al., 1992, Peselow et al., 1994, Ferro et al., 1998)
or may not (Loranger et al., 1991) inflate their true prevalence. In the post hoc
analyses, no significant differences were found in the prevalence of personality disorders
between those with current MDD vs. subMDD, which contradicts the view that a difference
between at least these levels of depressive symptoms would markedly influence personality
disorder prevalence.
Axis III diagnoses were evaluated by a specialist in general practice (M.Vuorilehto) via a
self-report questionnaire and information from medical records and the interview. Chronic
medical illness diagnosed by a doctor, minimum duration three months and with functional
impairment and/or constant suffering, was regarded as current somatic co-morbidity.
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8.2.4 Life-chart methodology and the definitions of outcome
The outcome of depression was investigated by using a graphic life-chart, identical to the
life-chart used in VDS (Melartin et al., 2004) and with many similarities with the
Longitudinal Interval Follow-up Evaluation (LIFE) methodology used in NIMH-CDS (Keller et
al., 1987). As in the LIFE, change points in the psychopathologic state were assessed
using probes related to important events; BDI ratings were used at three time-points and
all available patient records. Some degree of underestimation or fluctuation of
psychological symptoms, however, may have taken place due to possible recall bias. In this
study, patients’ follow-up time was classified into periods of DSM-IV MDE, partial
remission, and total remission. The major advantage of this classification is that it
counts episodes and defines recurrences precisely, as does any clinician when using the
DSM-IV.
However, as no universally accepted definitions of remission exist (Keller, 2003),
comparison with other studies using similar methodology but with different criteria for
remission, should be made with caution. Comparisons with other primary care studies cannot
be made, as only cross-sectional outcomes have been reported so far from comparable
patient samples.
8.2.5 Limitations of the study
The limitations of the study include moderate final sample size despite a rather large
screened patient population. Some subgroups remained small, especially the patients with
suicidal behaviour during the ongoing episode, due to the relative infrequency of suicidal
behaviour. Nevertheless, the main findings were statistically highly significant and
consistent. Concerning clinical history and the follow-up, to avoid recall bias, all
possible medical and psychiatric records were used to ensure correctness. Some degree of
underestimation or fluctuation of psychological symptoms, however, may have taken place
due to possible recall bias.
Concerning research on suicidal behaviour, the cross-sectional nature of the study limits
the possibility of making causal inferences. Moreover, when applying the results to
suicide prevention, it is to be remembered that this study only concerns non-fatal
suicidal behaviour. Despite the largely overlapping of clinical risk factors for suicide
attempts and completed suicides, these populations are known to be distinguished by at
least age, gender and method (Beautrais, 2001).
In the comparison between primary care and psychiatric settings, the main limitation is
the unavoidably different screening procedure of the two studies from which the samples
were drawn. The VDS included patients at the beginning of more intensive treatment, and
thus probably in their worst phase of depression. On the other hand, MDD in psychiatric
care might already have been somewhat alleviated due to treatment effects. The PC-VDS
focused on the cross-sectional load of MDD, thus comprising cases with a deteriorating, or
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already remitting phase of illness, or stable non-responders to treatment. Possible
inclusion of more chronic cases in the PC-VDS has been taken into account in the
regression models, which have been adjusted for the duration of the current episode.
Minor differences between the two diagnostic interviews in the comparison, SCAN and
SCID-I, could affect the prevalence of single diagnostic groups slightly. Therefore, we
included current alcohol dependence instead of total substance use disorders. Also Axis II
disorders in the DSM-III-R version compared with the DSM-IV version suggests slightly
altered number of items for antisocial and borderline personality disorders, this may
increase the prevalence of cluster B disorders in primary care with some percentages
(Mantere et al., 2004), but is unlikely to markedly influence the findings.
Concerning the factors associating with the outcome of MDD, those predictors were
deliberately focused on those that were present and recognizable to the doctor at intake.
Thus all events during follow-up were disregarded that may have influenced the course of
depression, including many psychosocial factors together with the complex process of
seeking, receiving and complying with treatment. The adequacy of treatment and reasons for
the scarce contacts for depression during follow-up is a subject of a further study; as a
baseline characteristic, current antidepressant treatment was an insignificant predictor
after adjusting for the severity of depression and therefore not included in the final
statistical models.
To the extent that other studies have investigated the same characteristics, no major
differences between these findings and those from primary care in other countries are
apparent.
8.2.6 The severity and long-term course of depressive disorders
The retrospective investigation showed a fluctuating course of depression in primary care,
where most depressive patients in fact suffer from MDD, although at the time of contact
are possibly in partial remission or a potential prodromal phase. The seemingly
cross-sectional "subsyndromal" depressions formed a heterogeneous group. Judd has
reported a comparable finding from a survey on the general population (Judd et al., 1997).
Furthermore, a large number of recurrences of depressive episodes and chronicity in a
fifth of MDD cases was found in this study, similar to the findings of population surveys
and studies in psychiatric settings (Solomon et al., 2000, Spijker et al., 2002).
8.2.7 Contacts with health care
Two thirds of depressive patients presented with somatic complaints as in earlier studies
(Gerber et al., 1992, Simon et al., 1999b), many of them with pain complaints, which may
often discriminate depressed patients from non-depressed (Gerber et al., 1992). No
association existed between somatic complaints and chronic somatic co-morbidity. Kroenke
has found that a third of primary care patients’ somatic symptoms are unexplained and
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correlate with anxiety and depression (Kroenke, 2003). In this study, presenting with
complaints of anxiety was rare, despite the high prevalence of co-morbid anxiety disorders
in the cohort; some somatic complaints may have arisen from somatic manifestations of
anxiety. An earlier finding of association between presenting with pain and having
co-morbid anxiety disorder was replicated here (Von Korff et al., 1996a).
It is noteworthy that despite the high level of psychiatric co-morbidity and thus multiple
concurrent psychiatric syndromes, co-morbid syndromes or symptoms exerted little influence
on the presenting complaint. Besides younger age, psychological presenting complaints
associated clearly only with higher severity of depression, which may partly explain why
milder cases are more often missed (Coyne et al., 1995, Harman et al., 2001, Thompson et
al., 2001). Similarly with individuals’ seeking of treatment in epidemiological studies
(Hämäläinen et al., 2004) primary care patients seem to present with psychological
symptoms mostly when their current level of depressive symptoms is distressing.
8.2.8 Co-morbidity
Co-morbidity was more a rule than an exception in this cohort, and only a tenth of
patients were free from any co-morbid psychiatric or chronic somatic illnesses. Of Axis I
disorders, anxiety (43%) and substance use disorders (12%) were most common. In addition,
the proportion of subjects with personality disorders (52%), especially borderline
personality (25%), was high. The pattern of co-morbidity was highly heterogeneous, with
often either somatic or psychiatric concurrent disorders dominating the clinical picture,
and variable in terms of severity and clinical significance. While some single co-morbid
disorders barely reached the diagnostic threshold and were of exclusively academic
interest, others formed disabling conditions of multiple clustered syndromes, particularly
when substance use and cluster B personality disorders were included. Altogether, it
appears that there is much more diagnostic heterogeneity and complexity in primary care
depression than is usually thought.
Co-morbidity may also have influence on the severity and course of depression. While the
number of co-morbid psychiatric illnesses associated with recurrence and chronicity, and
both Axis I and II co-morbidities associated strongly with the severity of depressive
symptoms − as also in the general population (Kessler et al., 2005b) - chronic somatic
illnesses had no influence on depression characteristics.
The prevalence rates of anxiety and personality disorders were higher in this cohort with
depression than in the general population (with or without depression) (Bijl et al., 1998,
Torgersen et al., 2001), but their presence here was roughly similar to findings in
individuals with MDD in population surveys (NCS-R) (Kessler et al., 2005b) and in
specialized care (Melartin et al., 2002). This suggests that they either strongly
associate with depression or with treatment-seeking from health care, or both.
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8.2.9 Suicidal behaviour
Suicidal behaviour clustered in a subgroup of patients with characteristics that had made
their depression recognisable such as severe symptoms of depression and personality
disorders. Their psychiatric characteristics appeared very similar to both unselected
suicide attempters (Hawton et al., 2003) and completed suicides (Foster et al., 1997,
Cavanagh et al., 2003, Arsenault-Lapierre et al., 2004). Non-fatal suicidal behaviour in
this study associated strongly with prior psychiatric care, either due to preceding
attempts or other psychopathology, similar to completed suicides among patients with
depression (Simon et al., 1998, Hoyer et al., 2004). The presence of at least one of
following risk indicators - personality disorder, prior treatment in psychiatric care, or
moderate to severe depression - had 94% sensitivity for any lifetime suicidal behaviour.
Personality disorder or prior psychiatric treatment had 100% sensitivity for lifetime
suicide attempts in this sample. Although the high risk patients in this sample were
already receiving care for their depression, the suicidal ideation itself had mostly
remained unnoticed, which is fully convergent with findings from psychological autopsy
studies of completed suicides (Isometsä et al., 1995).
8.2.10 Differences between primary care and psychiatric care in MDD
When comparing patients with MDD to those in psychiatric care, some differences between
settings seem rational and consistent with the principles suggested in practice
guidelines. Psychotic depression was present almost exclusively in the psychiatric
hospital. Moreover, the prevalences of suicidal ideation and attempts were highest there,
in line with Simon’s report of the highest suicide mortality being found in hospitalized
MDD patients (Simon et al., 1998, Simon et al., 2001).
The gradient of clinical severity and complexity, reported in general population surveys
as a factor that influence the choice of service provider (Hämäläinen et al., 2008), did
not associate in this study with professional help in all aspects. Differences in the
severity of depression between primary care and psychiatric outpatient care did not exist
in HAMD, although BDI scores were higher in psychiatric outpatient care when compared with
all patients in primary care with MDD; after excluding unrecognized MDD cases, however,
the difference lost significance. Earlier, higher HAMD scores in mental health services
were reported in the MOS, which also included milder depressions (Wells et al., 1995). By
contrast, comparisons of patients in need of treatment (Gaynes et al., 2005) or beginning
antidepressive medication (Simon et al., 2001) revealed no significant differences in
severity scores between settings. In complexity, only modest differences were found in
terms of Axis I co-morbidities, notwithstanding current alcohol dependence, which formed a
strong predictor for inpatient treatment and to a lesser extent for outpatient treatment.
This contradicts earlier reported similarities in current substance use disorders between
settings (Cooper-Patrick et al., 1994, Burns et al., 2000).
85
Personality disorders were present in equal number in all settings, but the clusters were
unevenly distributed: predominance of cluster A disorder was found in psychiatric care,
which might be related to its "odd" appearance. In primary care cluster B disorder, mostly
borderline personality disorder, was present in one-third of patients. To some extent,
this might relate to the chronicity of depression in primary care. Whether it also
reflects reluctance of primary care doctors to refer patients with poor motivation or
suspected non-adherence to more intensive treatment remains unknown.
8.2.11 Pathways in treatment among patients with MDD
In this study the patients, according to their pathways in treatment, may be traced in
various phases. Firstly, those with no contacts due to depression, representing the second
level of pathways to care introduced by Goldberg (Goldberg et al., 1980) made up one-third
of primary care MDD with a milder clinical picture, totally in line with many former
reports (Schwenk et al., 1996, Hämäläinen et al., 2004).
Thereafter, there are the patients who receive all of their treatment for depression in
only primary care (third level by Goldberg), in contrast to those who are later referred
to specialist care due to acute need or because treatment in primary care appears
insufficient (fourth and fifth level by Goldberg). The final number of patients and their
characteristics in these two groups will, besides depending on the recommendations for
referrals set forth in the national guidelines, also depend on local cooperation and
allocation of responsibilities. In the literature the choice of service provider is likely
to be influenced at least, besides patient preference (Fortney et al., 1998), by
co-morbidity and severity of depression, suicidal behaviour (ten Have et al., 2004,
Hämäläinen et al., 2008), and the availability of services (Fortney et al., 1998).
Finally, the last group in primary care comprises patients without remission of MDD who
are returning from specialist care as a consequence of treatment resistance, use of
insufficient treatment methods (Alonso et al., 2004b), or perhaps deliberate interruption
of treatment by the patients themselves (Melartin et al., 2005). In this study, this group
was characterized by rather severe symptoms, co-morbidity and suicidal behaviour. While
accounting for a large proportion (22%), this complicated group does not explain all of
the severity of depression in primary care. In the research literature the group of
patients returning from specialist care, but still suffering from a MDE, is generally
overlooked.
8.2.12 Outcome
The prognosis of MDD in primary care was more adverse than in many previous
cross-sectional outcome studies (Gaynes et al., 1999, Wagner et al., 2000). As in the
earlier studies, large proportions of partial remission (37%) and chronic course (25%)
emerged in this study; however, one-third of those with some remission later experienced
recurrence or relapse, leaving only one-quarter of patients with a sustained favourable
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outcome. Remission also appeared slowly; at six months, only half of the patients had
shown some recovery. The duration of MDE has been investigated in primary care earlier
only in a cohort of new patients, where the median duration was eight months (Oldehinkel
et al., 2000). Overall, our cross-sectional findings were consistent with previous
primary care studies, although the life-chart also revealed apparent recurrences and
fluctuation of symptoms alongside chronicity. Therefor, this information is fundamental
for developing management of depression in primary health care.
The main predictor for poor outcome was higher severity of depression. As in studies in
the general population (Spijker et al., 2002) and in psychiatric patients (Keller, 1992,
Mueller, 1996, Meyers et al., 2002, Melartin et al., 2004), baseline severity of
depression was associated with both chronicity and relapses or recurrences. Moreover, to a
lesser extent, co-morbid substance use disorders predicted chronic course of depression;
this association has been reported earlier in a univariate analysis in primary care
(Barkow et al., 2003). Antidepressive medication at baseline did not associate with
outcome in the models that were adjusted for severity of depression. Received treatment
may well have influenced the course of depression, but since the course also influences
the treatment, and severe symptoms usually associate with more intensive care (Simon et
al., 1995), this kind of observational study may end up with no association.
The influence of personality disorders on outcome of depression has previously remained
unexamined. Here, cluster C personality disorders appeared to predict early recurrences.
Previously, a general population survey (Johnson et al., 2005) reported a similar
association, while in specialist care, cluster C personality disorders have mainly been
associated with longer duration of MDE (Viinamäki et al., 2002, Farabaugh et al., 2005).
Finally, chronic medical illnesses, a known predictor for adverse cross-sectional outcome
in both adult and elderly patient groups (Wagner et al., 2000, van den Brink et al.,
2002), also formed a risk factor for slow recovery from subsyndromal depression in this
cohort.
Concerning subsyndromal depressive disorders the significance of lifetime history of MDD
for expected outcome was revealed. While "proper" MinD seldom proceeded to MDE, a new
MDE was seen in one-third of those who were in partial remission or in a potential prodromal
phase of lifetime MDD. Overall, however, as in the few existing cross-sectional studies
(Ormel et al., 1993, Wagner et al., 2000, Lyness et al., 2002), the group with
subsyndromal depressive disorders had a better prognosis. As they at entry already had
fewer co-morbid psychiatric disorders, they may represent a group in a clinical subgroup
of patients more likely to recover.
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9  CONCLUSIONS AND IMPLICATIONS
9.1 Conclusions
This study provides a unique clinical picture of the total caseload of primary care
depression − both recognized and unrecognized. A broad spectrum of co-morbidity and other
clinical characteristics has been assessed, as well as both retrospective and detailed
prospective course. Exceptionally, comparison of comparable characteristics of primary
care patients with MDD and patients in secondary psychiatric care in the same catchement
area has also been possible.
From a lifetime perspective, the majority of primary care patients with depressive
disorders suffer from recurrent MDD, and most of the subsyndromal cases represent in fact
either prodromal or residual phase of MDD. In prospective investigation, fluctuating
course, with high rates of recurrence and chronicity could be verified.
The majority of primary care depression is mild or moderate MDD and complicated by highly
prevalent psychiatric and somatic co-morbidity. The cross-sectional caseload of depression
consists of a remarkable minority of chronic patients. The clinical picture of MDD is very
similar to that in psychiatric outpatient care whereas patients with severe, psychotic and
suicidal depression were clustered in psychiatric inpatient care.
Severity of depressive symptoms and co-morbidity are also important predictors for
prognosis in primary care. Together with treatment history in psychiatric care, severe MDD
and co-morbid personality disorder clusters with suicidal behaviour. Moreover, severity of
depression serves well as a predictor of outcome.
9.2 Clinical and research implications
Treatment of depression in primary care cannot rest on an assumption of short-lived,
uncomplicated mild disorders. The direction of clinical implications from the longitudinal
findings is clear: in clinical decision-making, a history of previous MDD should not be
ignored by primary care doctors while depression is usually severe enough to indicate at
least follow-up, and concerning those with residual symptoms, also evaluation of their
current treatment in order to avoid the high risk of later relapse. Questioning about
prior treated episodes, as a clue for clinically significant depression, should be
expanded to gathering information on all prior depressive symptoms in order to obtain a
88
full picture of the course of depression. Severity of depression serves well as a
predictor of outcome; primary care doctors in everyday practice should consider this.
Moreover, recognition of suicidal behaviour among depressed patients should also be
improved. The complex psychopathology of suicidal depressed patients in primary care needs
to be considered in targeting preventive efforts; standard antidepressant therapy in
primary care is only a partial solution. Effective treatments that take into account the
complex psychopathology need to be developed and evaluated, but what treatment and what
kind of cooperation between settings would best benefit them, remains uncertain.
In order to improve outcome of depression in primary care, the often chronic and recurrent
nature of depression should be taken into account. Because of the high number of recurrent
cases in primary care, long-term maintenance treatment there is often warranted. The
findings of this study also support the need of other than acute treatment of depression.
A challenging focus of future research on primary care depression is the management of
care, both in communal health centres and in occupational health care. Best ways of
allocating resources between treatment providers should be found, as well as the optimal
ways of dividing the responsibilities between various kinds of primary care workers and
specialists; an integrative view should be reached. Additionally, the ways in which
depression care could be integrated into the treatment of medically ill patients is a
challenge and an option scarcely used in primary care. Finally, a significant minority
with multiple co-morbidity, chronic course of depression and already unsuccessful
treatment trials in specialist care is a group needing further examination with the
possible development of special treatment programs.
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